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Chapter 5. Longitudinal Cohort Study of PMWS-affected and non-affected
Postweaning Multisystemic Wasting Syndrome (PMWS) is a recently emerged 
multifactorial clinical disease of swine that affects nursery and growing pigs and 
PCV2 is believed to be the main aetiological agent of the disease. PMWS has 
emerged in Ireland as a clinical entity in pig herds so there was therefore a need to 
determine the extent of PCV2 infection and associated disease in the pig population of 
Ireland.
The prevalence of PCV2 in Ireland was determined by testing a percentage of porcine 
sera for antibodies to PCV2 using the IPMA method; this method is based on PCV- 
free PK15 cell cultures infected with PCV2 virus. Ten serum samples (where 
available) from fifty randomly selected herds (426 sera samples) were tested, of the 
fifty herds only four were negative to PCV2. However these four herds were all 
hobby herds (less than 12 pigs). In most cases of the ten samples tested per herd eight 
to ten of the sera samples were positive for PCV2 antibodies indicating that there is 
widespread seroconversion to PCV2 in Ireland.
To determine the extent and emergence of the disease a study on suspect herds was 
performed. This study commenced on the 1st January 2004 and was completed on the 
1st January 2005. This study involved working in collaboration with local pig 
veterinarians and regional veterinary laboratories so that any herd that developed any 
syndromes typical/similar to PMWS were reported and suspect herds tested for the 
presence of PCV2 antigen. Tissue samples (especially lymph nodes) were taken from 
necropsied pigs (approximately 4 per herd) and tested by using a combination of 
indirect fluorescent antibody staining of cryostat tissue sections,
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immunohistochemsitry and histopathology. A total of 30 suspect herds in Republic of 
Ireland were tested over this twelve month period. 24 of these herds were found to be 
positive for PMWS and 6 herds negative. In Northern Ireland, 31 herds were tested 
and 14 of these herds were PMWS positive, based on PCV2 antigen levels.
PCV2 was isolated from diseased and non-diseased pigs in Ireland. The entire 
genome of PCV2 was amplified by PCR sequenced. Complete genomes of PCV2 
were then aligned and a phylogentic analysis was performed. ROI and NI isolates 
were closely related to each other displaying 97-100% overall nucleotide homology. 
An amino acid (aa) alignment was performed on the two major Open Reading 
Frames, ORF1 and ORF2, as these encoded the major proteins, Replicase and Capsid, 
respectively. The majority of aa changes observed between PMWS positive and 
negative isolates occurred within ORF1.
A detailed longitudinal study was also carried out. A total of 4 herds were involved in 
the study, 2 herds from ROI which were reported as positive for the disease, one 
negative control herd from ROI and one positive herd from NI. The study involved 
monitoring approximately 5 litters from each of the 4 herds for a total of 10 weeks 
from birth in order to elucidate any co-factors that may lead to PMWS. Serum 
samples were tested for PCV2 antibody titre and PPV antibody, tonsil and faeces 
samples were tested for the presence of other viruses such as enterovirus 1 and 2, 
reovirus and adenovirus and faecal swabs for bacterial organisms such as haemolytic 
E . c o l i ,  C a m p y l o b a c t e r  spp. and S a l m o n e l l a e  spp. From the study it could be 
concluded that there was no distinguishable coinfection of PCV2 with any of the 
infectious organisms mentioned between positive and negative animals and herds.
Chapter 1: Literature Review
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In 1974, reseasrchers in Germany described a new, non-cytopathogenic, 
picomavirus-like contaminant in the porcine cell line, PK-15 (ATCC-CCL33). This 
name porcine circovirus (PCV) was proposed (Tischer e t  a l . , 1982). Serological surveys 
for PCV antibodies revealed that the virus was widespread in the swine population. 
However, experimental infections of newborn to nine-month old conventional pigs with 
PCV did not result in clinical disease and the virus was regarded as non-pathogenic 
(Tischer e t  a l . ,  1986, Allan e t  a l . ,  1995).
In the late 1990’s, an apparently novel PCV-like virus was first isolated from pigs 
with a wasting disease in Western Canada (Ellis e t  a l , 1998). Shortly afterwards, almost 
identical viruses to this Canadian isolate were also recovered from diseased pigs in North 
America and Europe (Allan e t  a l . , 1998b). These PCV virus isolates were shown to be 
antigenically and genetically distinct from the PCV contaminant of PK-15 cell cultures. 
It was proposed that the PCV isolates from diseased pigs should be designated porcine 
circovirus type 2 (PCV2) and the original PCV contaminant of PK-15 cell cultures 
designated porcine circovirus type 1 (PCV1) (Allan e t  a l , 1999b).
PCV2 has since been associated with a number of disease syndromes in pigs and 
is now recognized at the casual agent of Postweaning Multisystemic Wasting Syndrome 
(PMWS), which is the subject of this study.
1.1 Introduction
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1.2 C ircoviridae
PCV2 is a member of the family C ir c o v i r id a e , a recently established family 
composed of small, non-enveloped, isometric DNA viruses with a circular single 
stranded DNA genome. This family is divided into two genera based on virion size and 
genomic organisation; C ir c o v i r u s  and G y r o v i r u s  (Mankertz e t  a l . , 2004). PCV2 is 
classified in the genus C ir c o v i r u s . Other members of the genus circovirus include; 
porcine circovirus type 1 (PCV1); beak and feather disease virus; goose circovirus; 
canary circovirus; the human TT virus. (Kim and Chae, 2001; Todd e t  a l , 2000; Cheung, 
2004a). Circoviruses are characterised by a very compact genomic structure. In all 
viruses from the genus C ir c o v i r u s , an intergenic region is flanked by two head to head 
arranged open reading frames. Circoviruses are the smallest known animal viruses, 
approximately 12 -  27nm in diameter, that replicate autonomously in mammalian cells. 
The DNA molecules are approximately 2,000 nucleotides in length, encoding two major 
ambisense open reading frames (Grierson, 2004b). Circoviruses appear to have an 
affinity for tissues and cells of the immune system, such as macrophages and epithelial 
cells and are highly resistant to inactivation by detergents and disinfectants (Segales and 
Domingo, 2002; Chae, 2004).
1.2.1 Porcine Circovirus Type 1 (PCVI)
PCV1, first described in 1974, is a non-enveloped virus of 17 nm diameter 
containing SS circular DNA of only 0.58xl06 daltons. It has a buoyant density of 1.37 
gm/cm3 in cesium gradients, does not haemagglutinate erythocytes and is resistant to 
inactivation by exposure to pH 3.0, c h lo r o f o r m  and heating at 56 or 70°C (Allan e t  a l . ,
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1994a). It is probable that these properties are common to both PCV1 and PCV2. The 
virus multiplies in primary and permanent cell cultures of porcine origin where it causes a 
persistent infection (Tischer, 1986). PCV1 is non-pathogenic and infection is thought to 
be ubiquitous throughout the pig population (Walker e t  a ir , 2000). The presence of 
PCV1 has not been associated with any recognised clinical signs or pathology and 
experimental infection of pigs (with this virus) has failed to produce clinical disease 
(Tischer, 1986; Meehan e t  a l . , 1998; Allan and Ellis 2000a; Allan, 2002; Segales and 
Domingo, 2002).
1.2.2 Porcine Circovirus Type 2 (PCV2)
Nucleotide sequence analysis of the circovirus isolates associated with PMWS, 
PCV2, revealed important differences compared to the previously known circovirus 
derived from PK-15, PCV1. The circular PCV2 genome contains 1767-68 nucleotides 
(Meehan e t  a l . ,  1998; Hamel e t  a l . , 2000; Mankertz e t  a l . ,  2000) and genomic analysis of 
PCV2 virus from pigs around the world has shown that they belong to a phylogenetic 
cluster with a nucleotide sequence identity greater than 94% (Meehan e t  a l . , 1998; 
Mankertz e t  a l . , 2000; Larochelle e t  a l . , 2002). Potentially, six ORFs larger than 200 
nucleotides have been suggested for the PCV2 genome but proteins seem to be expressed 
only by ORF1 and ORF2. Little is known about the significance of the potential smaller 
ORFs. Little data exist on the biological and physio-chemical characteristics of PCV2. 
Exposure of PCV2 for 10 minutes at room temperature to a number of commercial 
disinfectants based on chlorhexidine, formaldehyde, iodine and alcohols leads to a 1.8 to
4.4 log TCID5 0  reduction in virus titre (Royer e t  a l . , 2001).
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The distinct pathogenicity of PCV2 seems to be the most striking difference 
between the PCV1 and PCV2. PCV2 isolates have 80% nucleotide identity with PCV1 
isolates. Both PCV1 and PCV2 contain two major open reading frames (ORF’s) named 
ORF1 and ORF2, which encode the Rep (replicase) and Cap (capsid structural protein) 
proteins respectively. Sequence conservation between the c a p  and r e p  genes of PCVI 
and PCV2 differs considerably (Cheung, 2004a). The origin of replication (Ori) and the 
r e p  gene, both involved in replication of the virus is conserved in 79.5 and 82% of the 
nucleotides, while the c a p  gene shows a higher sequence deviation between the two 
strains with 62%. Since the c a p  gene seems to be the only gene product substantially 
altered, it may contribute to the different pathogenicities of PCV1 and PCV2 (Segalés 
and Domingo, 2002; Mankertz e t  a l . , 2004).
The potential formation of a palindromic structure as a result of interactions 
between the inverted repeats (palindrome) at the origin of DNA replication (Ori) and 
similarities among the putative proteins essential for virus replication indicate that PCV 
DNA may replicate via the rolling-circle replication stem-loop or via a recently proposed 
rolling-circle replication (RCR) “melting-pot” model (Cheung, 2004a; Cheung, 2004b). 
The Rep proteins of PCV contain the three conserved RCR motifs (RCR-I, II, III) and 
NTP-binding core homologous to the Rep proteins of other prokaryotic and eukaryotic 
RCR systems. Replication of PCV DNA requires two proteins (Rep and Rep’) instead of 
just one multifunctional Rep protein. PCV1 and PCV2 each contain a nona-nucleotide 
that is flanked by a pair of palindromic sequences. It has been reported that the nona-
1.2.3 Comparison of PC V1 and PCV2
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nucloetide and the palindrome are critical for PCV DNA replication (Cheung, 2004a; 
Cheung, 2004b).
1.3 Post-w eaning M ultisystem ic W asting Syndrom e
PMWS is a recently described multi-factorial clinical entity, which affects nursery 
and growing pigs. The designation PMWS was coined to describe a clinical condition 
which is characterized by progressive loss of condition, associated with lesions in several 
organ systems. The disease was first identified in 1991 in Saskatchewan, Western 
Canada in a high health specific pathogen free (SPF) herd and was reported in 1996 
(Clark, 1997; Chae, 2004) (Harding, 1996; Harding, 1997; Meehan e t  a l . ,  1998; Allan, 
2002; Segales and Domingo, 2002; Darwich e t  a l . , 2004; Allan, 2005). This herd was 
free of the major enteric and respiratory pathogens that affect swine including porcine 
parvovirus (PPV), porcine reproductive and respiratory syndrome virus (PRRSV), 
aujeszky’s disease virus (ADV), and did not demonstrate mycoplasmal or actinobacillary 
pneumonia, atrophic rhinitis, salmonellosis, swine dysentery and transmissible 
gastroenteritis. The overall pathogen load was low with low incidence of medical 
treatment and low mortality in the herd.
The reasons for the emergence of epidemic PMWS in the 1990s are not 
understood; but since its occurrence the disease has resulted in major economical and 
welfare problems to pig farmers (Grierson e t  a l . , 2004a). It has been estimated that 
PMWS costs around €600 million per year to the European Union (Armstrong, 2004;
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Allan, 2005). Direct losses come from mortality in the nursery and fattening pigs, and 
from unthrifty pigs unable to reach market weight. Indirect losses come from increased 
use of antibiotics in an attempt to control concurrent bacterial infections, and changes in 
farm management practices in an attempt to reduce the impact of PMWS.
PMWS appears to be a multifactorial syndrome. However, it has been 
demonstrated that porcine circovirus type 2 (PCV2) plays a crucial role in the 
pathogenesis of PMWS in pigs and is now recognized as the significant aetiological agent 
of the disease (Segales and Domingo, 2002). PCV2 nucleic acid and antigen has been 
demonstrated in abundance within the lesions of affected pigs and the subsequent 
isolation and characterisation of a PCV2 virus from diseased pigs was reported (Ellis e t  
a l . ,  1998).
1.3.1 Coinfection with other agents
To demonstrate if porcine circovirus is the causative agent of PMWS many 
consistent and repeatable disease models have been developed using infectious (Allan et 
al, 1999a; Krakowka e t  a l . ,  2000; Allan e t  a l . ,  2003) and non-infectious (Krakowka e t  a l . ,  
2001) co-factors (Allan, 2005). Tischer e t  a l  carried out the first of these experiments in 
1986. Six minipigs at the age of 9 months with no antibodies to PCVs were intranasally 
infected with PCV1. However, the pigs showed no signs of disease, nor could any 
increase in body temperature be measured. However, all pigs were seen to seroconvert to 
PCV1. Post-mortem and histopathological examination gave no indication of a specific 
virus disease. The same experiment was then carried out on newborn pigs to determine if
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the younger pigs would become ill more readily than the older pigs. Again no signs of 
disease developed in these pigs (Tischer, 1986). The presence of PCV2 antigen has been 
demonstrated in lesions of animals affected by PMWS (Ellis e t  a l . , 1998). Balasch e t  a l  
(1999) inoculated conventional pigs from high health status farms with tissue 
homogentates from pigs with PMWS intranasally. Pigs were necropsied 14 or 21 days 
post inoculation (dpi). PCV2 nucleic acid was found in close association with 
microscopic lesions showing that PCV2 is transmissible to pigs by the nasal route 
(Balasch e t  a l . , 1999). In another study carried out by Magar e t  a l  (2000) lesions were 
seen to first occur in the lungs demonstrating the respiratory system as a route of entry. 
Alternatively, PCV2 may infect the nasopharynx and tonsils and spread to other sites in 
mononuclear cells via the blood or lymph (Magar e t  a l . , 2000b). In the study carried out 
by Balasch e t  a l  (1999) severe clinical signs were not reproduced, although, some pigs 
showed comparatively mild signs such as diarrhoea, increased rectal temperatures and 
reduced average daily weight gain. Failure to reproduce PMWS clinically was also 
reported by Lecann e t  a l  (1997). Microscopic lesions, similar in type and location to 
those described in pigs with naturally occurring PMWS but not as intense, were reported 
and a strong relationship was observed between the lesions and the detection of PCV2 as 
is in natural cases of PMWS (Balasch e t  a l . , 1999).
The failure of the above mentioned experimental models to reproduce clinical 
disease when pigs were infected with PCV2 alone led to further investigations. In an 
experiment designed by Ellis e t  a l ;  (1999) to determine the involvement of the novel 
PCV2 virus isolate (PCV-Saskatoon-7) in PMWS, neonatal gnotobiotic piglets were
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inoculated with tissue homogenates from low and high passage cell culture material. 
Gnotobiotic piglets were used in order to exclude any external environmental sources of 
infectious or toxic material. However, the inoculum, was subsequently shown to have 
been coinfected with porcine parvovirus (PPV). Evidence of PPV in lesions typical of 
PMWS in these inoculated piglets suggested this virus may also play a role in the 
pathogenesis of the field syndrome. PPV is endemic in swine populations and many 
weaned pigs may be infected with PPV. PPV has only rarely been associated with any 
disease in piglets other than foetal death. All pigs were infected intranasally, again 
suggesting that the disease can be transmitted by this route via the respiratory or digestive 
tracts. Clinical signs were not consistently observed in the gnotobiotes in spite of the 
presence of gross and histological lesions characteristic of PMWS. However, lesions 
observed in pigs coinfected with PCV2 and PPV in this study included lymphadenopathy 
of bronchial nodes with prominent giant cells, interstitial pneumonia and multifocal 
myositis involving smooth and cardiac muscle (Ellis, 1999). The absence of clinical 
signs in this case may have been due to the absence of environmental stressors such as 
management practices, exogenous microflora or pathogens that could be cofactors in the 
development of disease. In addition, the inocula had relatively low titres of PCV2 and 
PPV (Ellis, 1999). This accidental inoculation of the pigs with a combination of the two 
viruses led to further studies investigating the effects of the two viruses when inoculated 
intranasally either singly or in combination into colostrum deprived conventional pigs. In 
studies carried out by Kennedy e t  a l , (2000), pigs inoculated with PCV2 alone developed 
mild to moderate histopathological changes characteristic of PMWS. Virus was isolated 
from tissues, indicating that lesions of PMWS can be induced by inoculating pigs with
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PCV2 alone, thereby fulfilling Koch’s postulates. In pigs inoculated with both PCV2 and 
PPV, severe clinical signs including jaundice and severe microscopical lesions 
characteristic of PMWS developed. Pigs infected with PPV alone, developed mild 
interstitial nephritis which was indistinguishable from that in those animals infected with 
PCV2 alone and were associated with the presence of PPV antigen in tubular epithelium 
cells. Concurrent infection with PPV increased the severity of lesions suggesting this and 
other agents may play an important role in modifying the clinical and pathological 
expression of PCV2 infection (Kennedy e t  a l . ,  2000).
Field studies were then necessary to determine if these viruses interact in naturally 
acquired PMWS. Affected tissues from field cases were examined by 
immunohistochemistry (IHC) and polymerase chain reaction (PCR) to determine if a 
synergistic effect of the two viruses in producing clinical disease existed. Both PPV and 
PCV2 are small, SS DNA viruses that have a small coding capacity and are therefore 
highly dependent on host cell functions. Little is known of the requirements for growth 
of PCV2 in  v iv o , only that it is dependent on the S-phase of cell-cycle. It has been 
hypothesised that replication of both PCV2 and PPV depends on cellular enzymes 
expressed during the S-phase. Therefore, these viruses may target the same cells in  v iv o  
and may interact in some way to synergistically enhance replication. The same 
physiological factors may enhance replication of both viruses and so the presence of both 
PPV and PCV2 in lesion sites could be related to disease. Another theory suggested by 
Ellis e t  a l  (2000) is that viral antigens in phagocytic cells in lesion sites may have been 
engulfed at extralesional sites and transported intracellularly into sites of tissue damage.
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It has also been suggested that replication of both PCV2 and PPV may occur in rapidly 
replicating cells in sites of pre-existing tissue damage (Ellis e t  a l , 2000). PCV2 and PPV 
have a predilection for lymphoid tissue. Therefore replication of these agents in 
synchrony could have profound immunomodulating consequences and predispose to 
debility and secondary infections (Allan et al, 1999a; Ellis e t  a l , 2000).
In the study mentioned above carried out by Kennedy e t  a l ,  (2000) both viruses 
were detected in typical lesions of PMWS. It has therefore being suggested that PPV 
may be one of several cofactors, including other infectious agents such as PRRSV, that 
act synergistically with PCV2 in the pathogenises of PMWS.
To determine the involvement of other pathogens in the development of PMWS, 
other experimental models were created, some of which involved the coinfection of pigs 
with PCV2 and porcine reproductive and respiratory syndrome virus (PRRSV). PRRS is 
one of the most significant infectious diseases affecting the swine industry. Evidence 
from field surveys suggests that coinfections of pigs with these two viruses is common 
(Allan e t  a l ,  2000b) as PCV2 is ubiquitous in the pig population and PRRS is also very 
common in pigs. Preliminary studies have shown that both PCV2 and PRRSV were 
present in the livers of sows with PRRS-associated hepatitis and both PRRSV and PCV2 
antigen or genome have been detected in tissues from the majority of PMWS cases 
(Harms e t  a l ,  2001). However, the detection of PCV2 and PRRSV in the same animals 
may only be co-incidence as these are two infectious agents with a high prevalence in 
commercial pig populations. Harms e t  a l , (2001) infected 3- week old caesarean-derived,
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colostrum-deprived (CD/CD) piglets with PCV2 alone, PRRSV alone and a combination 
of the two viruses. PCV2 alone was found to be pathogenic in CD/CD pigs and this 
corroborates the findings mentioned earlier. Coinfection with PCV2 and PRRSV induced 
severe clinical disease, high mortality and lesions consistent with PMWS (Harms e t  a l ,  
2001). Allan e t  a l , (2000b) also infected colostrum deprived pigs with PCV2 alone, 
PRRSV alone and a combination of the two. Neither clinical disease nor gross lesions 
were observed in pigs inoculated with PCV2 or PRRSV alone. Pigs inoculated with both 
viruses in this experiment did not exhibit clinical disease, but it is possible that disease 
and gross lesions would have occurred if the experiment was not terminated at 28 days 
PI. In the pigs inoculated with PRRSV alone or the combination of the two, PRRSV 
antigen was only sporadically detected in minimal amounts, indicating that PCV2 
infection does not potentiate PRRSV replication. In contrast, in pigs inoculated with 
PCV2/PRRSV, PCV2 viral load and tissue distribution was enhanced when compared to 
pigs inoculated with PCV2 alone. Results of this study suggest that previously reported 
potentiation of PCV2 replication in pigs following coinfection with PPV is not unique 
and that coinfection of pigs with PCV2 and PRRSV also potentiates PCV2 replication. 
The commonality of target cell types for these viruses may play an important part in this 
synergism. The results possibly negate the proposed hypothesis that PCV2/PPV 
synergism may be related to the dependence for growth of both of these viruses on 
cellular enzymes expressed in the S phase of cell replication (Allan e t  a l , 2000b).
Similar experimental infections were also carried out by Rovira e t  a l , (2002) 
using conventional pigs. Prior to inoculation all pigs were sero-negative to PRRSV and
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had low titres of antibodies to PCV2. In the dual inoculated pigs increased rectal 
temperature (>40.5°C), wasting, severe respiratory distress and intense paleness was 
observed and PMWS was reproduced. In the pigs inoculated with PRRSV alone, no 
respiratory clinical signs developed. However, the average daily weight gain was lower, 
wasting was observed and reduced feed conversion rates were detected. Finally, in pigs 
inoculated with PCV2 alone, the pigs became infected but no clinical signs developed. 
The amount of PCV2 nucleic acid detected was higher in PRRSV/PCV2 inoculated pigs 
than in PCV2 only inoculated pigs and was present in a wider range of tissues. This 
suggests that PRRSV infection promotes the replication of PCV2 (Rovira e t  a l . , 2002). 
Because PPV and PRRSV may potentiate PCV2 infection, other infectious agents such as 
C r y p to s p o r id i u m  p a r v u m ,  (Nunez e t  a l . , 2003), and pulmonary aspergillosis (Segales e t  
a l . ,  2003b) may have similar effects.
In all experimental models mentioned, it is possible that a number of other factors 
such as the age and source of the pigs, the environmental condition in which the pigs 
were held, the genetics of the pigs and the nature of the PCV2 inoculum used, may have 
played a role in the consistent experimental reproducibility of the disease.
1.3.2 Transmission of PC V2 Infection
The oronasal route (Balasch e t  a l . ,  1999) is considered the most likely route of 
PCV2 transmission as supported by experimental studies on PCV2 infection, which have 
mainly used the intranasal route of inoculation (Allan et al, 1999aa; Ellis e t  a l . , 1999; 
Krakowka e t  a l . , 2000; Krakowka e t  a l . ,  2001; Rovira e t  a l . ,  2002). Under field
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conditions the majority of pigs seroconvert to PCV2 between 2 and 4 months of age 
indicating that horizontal transmission of PCV2 between pigs is very efficient. 
Horizontal transmission to susceptible pigs commingled with already infected pigs has 
been demonstrated under experimental conditions (Albina e t  a l . , 2001; Bolin e t  a l . , 2001; 
Allan, 2005). Cloned genomic DNAs of PCV2 have been shown to be infectious and 
capable of producing histological lesions consistent with PMWS, when injected 
intramuscularly, intraperitoneally or directly into the liver or lymph nodes of pigs 
(Fenaux e t  a l . , 2002; Roca e t  a l . , 2004; Allan e t  a l . , 2005). Transplacental transmission 
of PCV2 has recently been demonstrated following intranasal infection of sows (Park e t  
a l . , 2005) indicating that vertical transmission of PCV2 is feasible. Recent data from 
Korea has shown PCV2 infection in about 13% of aborted foetuses and stillborn piglets 
(Kim J., 2004).
1.4 E pidem iology
Since it was first described PCV2-associated PMWS is now recognized in most 
pig producing countries (where pigs are both intensively and extensively produced) in 
Europe, North and South America and eastern Asia (Chae, 2004). In Europe PMWS was 
first diagnosed in France in 1996 and then it was subsequently diagnosed across Europe, 
Table 1.1. A similar situation was observed in Asia where the disease has been known 
since 1995 in Taiwan, 1996 in Japan, 1998 in Thailand and 2000 in South Korea. The 
disease was also seen to emerge in the North Island of New Zealand in September 2003 
(Laval, 2004).
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Year PMWS first Diagnosed Country
1991 Canada
1995 Taiwan
1996 Japan
1996 France
1997 Spain
1997 Belgium
1997 The Netherlands
1998 Thailand
1998 Northern Ireland
1998 Germany
1999 England
1999 Italy
1999 Hungary
1999 Greece
1999 Czech Republic
2000 South Korea
2002 Croatia
2003 New Zealand
Table 1.1: Emergence of PMWS
It was originally believed that PCV2 was a ‘new’ virus of the C ir c o v i r i d a e  family. 
However, recent testing of archived tissue samples has shown that infection with PCV2 
in the pig population in many countries existed prior to emergence of clinical disease 
(Magar e t  a l . , 2000a; Bielanski e t  a l . , 2004). PCV2 has been detected in archived porcine 
tissues as far back as, 1969 in Belguim, 1973 in Northern Ireland, 1986 in Switzerland, 
Canada and Spain, 1989 in Japan and 1993 in Thailand (Staebler e t  a l . ) . PCV2 is now 
considered a ubiquitous virus both in countries where PMWS has or has not been 
detected (Allan e t  a l , 2000a; Segales e t  a l . , 2004a). This would suggest that the host- 
virus relationship was formerly one of a stable sub-clinical persistent infection. Clinical 
disease associated with PCV2 infection is now widespread and nucleic acid and antigen
have been demonstrated in abundance in tissues of pigs with and without PMWS. The 
question remains what has caused this change in the symbiotic relationship between 
PCV2 and the pig population and what is now triggering (PCV2 to cause the) clinical 
disease in some pigs? Detection and genetic typing of PCV2 DNA in archived paraffin 
wax-embedded tissues was carried out to confirm the presence of PCV2 in the British pig 
population since at least 1970. Of the samples tested, 41% from the 1990’s, 31% from 
the 1980’s and 32% from the 1970’s were found to be positive for PCV2 by PCR and 
IHC. PMWS as a disease only recently emerged and it was thought that maybe changes 
to the PCV2 genome could account for an apparent increase in virulence. However, 
recent experimental reproduction of PMWS using a Swedish isolate (when Sweeden was 
free of PMWS) provides strong evidence against varying virulence of PCV2 isolates 
being responsible. It has been hypothesised that the involvement of extraneous 
agents/factors, in combination with other viral agents, including various microbial agents 
and components of modem intensive farming practices and modem husbandry practices 
such as early weaning, or immunological or other stresses are contributory factors to the 
incidence of PMWS today. High genetic similarity between archival samples and 
contemporary isolates provide evidence against the involvement of a ‘new’ or modified 
virus in the aetiology of PMWS (Grierson, 2004b).
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PMWS is now recognised as a disease of pigs where PCV2 infection is needed for 
expression of the clinical condition. However, it is also recognised that PCV2 infection, 
linked to other co-factors, is necessary for the consistent development of full clinical 
disease in pigs (Allan e t  a l , 2005). Up to 20% of pigs that develop this disease may 
recover. In these animals clinical signs and lymphoid lesions may resemble those found 
in the initial stages of disease. However, most pigs infected with PCV2 will not develop 
clinical PMWS. When clinical PMWS is apparent, damage to the immune system is the 
main feature in affected pigs. Lymphocyte depletion of lymphoid tissues, changes in 
peripheral blood mononuclear cell (PBMC) sub-populations and altered cytokine 
expression patterns are common in both natural and experimental cases of PMWS in pigs 
(Clark, 1997; Rosell e t  a l . , 1999; Darwich e t  a l . , 2003a; Darwich e t  a l . , 2003b; Nielsen e t  
a l . , 2003). Pigs with PMWS show different degrees of wasting, generalized 
lymphadenopathy, non-collapsed and tan-mottled lungs, sometimes with very marked 
interstitial oedema (Segales and Domingo, 2002). Less frequently, hepatic atrophy and 
kidney lesions may also be present. Thin-walled, fluid-filled intestines have also been 
found especially in the ileum and spiral colon (Krakowka S., 2003; Darwich L., 2004, ). 
PCV2 can also induce hepatitis and liver failure is one of the causes of death in PMWS- 
affected pigs (Rosell e t  a l . , 2000; Krakowka e t  a l . , 2001).
The pathogeneses of naturally acquired PCV2 infection has not been fully 
characterised (Segales e t  a l , 2004). Little is known about the growth of PCVs in their 
natural host or the tissues involved in PCV2 replication. As mentioned, it has been
1.5 Pathogenesis
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speculated that viral transmission may occur vertically, by direct (oro-nasal) or sexual 
contact, since PCV2 has been detected in nasal cavaties (Sibila e t  a l , 2001), semen 
(Hamel e t  a l , 2000) and in foetuses between 32 and 114 days gestation (Ohlinger and 
Pesch, 2000). Still unknown is the identity of cells that support PCV2 replication. In 
naturally affected PMWS in pigs initial PCV2 replication probably takes place in 
macrophages and lymphoid tissues such as tonsil and regional lymph nodes or Peyer’s 
patches if virus is swallowed and survives the low pH of the stomach (Royer e t  a l . ,  
2001). After infection and replication in the resident mucosal macrophages and other 
antigen-presenting cells, PCV2 might be transported either intracellularly or free in 
lymph and/or blood. The normal traffic of PCV2 target cells to many tissues may 
contribute to the spread of viral infection to numerous organs (Rosell e t  a l . , 1999). It 
appears that histiocytic infiltration is one of the initial events during PCV2 infection and 
coincides with macroscopic lymphadenopathy (Segales e t  a l . ,  2004b). However, it has 
also been noted that the large amount of PCV2 viral antigen found in macrophages and 
dentritic cells of diseased pigs appears to be the result of the accumulation of viral 
particles (Gilpin e t  a l . , 2003; Vincent e t  a l . , 2003) and not the result of active virus 
replication in these cells.
It has been shown that some virus-infected tissues are free of pathological 
changes but in general, changes can be found in almost all tissues in severely PMWS- 
affected pigs. Generally, the more severe the lymphoid lesions, the higher the number of 
PCV2 infected tissues. No direct correlation has been found between the severity of 
PMWS lymphoid lesions and the severity of lesions in other tissues such as lung, liver or
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kidney. The pathogenesis of naturally occurring PCV2 infection in adult pigs is highly 
speculative. A suggested pathogenic scheme for PCV2 infection in nursery and fattening 
pigs is outlined below in figure 1.1 (Segales e t  a l . , 2004a):
PORCINE CIRCOVIRUS TYPE 2 (PCV2) INFECTION
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Figure 1.1: Suggested pathogenesis of natural PCV2 infection
It has been proposed that infection with PCV2 in particular conditions may be a 
cause of secondary immunodeficiency as a result of other organisms in pigs (Segales e t  
a l . , 2004b). Primary or secondary immunodeficiency increases the susceptibility of 
animals to infectious organisms of normally low pathogenicity or from an attenuated live 
vaccine. Immunodeficiency can manifest as recurrent illnesses that are usually difficult 
to control, failure to respond adequately to vaccination, unexplained neonatal illness and
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death affecting more than one animal in a litter, and a variety of disease syndromes 
occurring concurrently in a herd. Some of these findings have been extensively described 
in PMWS outbreaks. The lack of antibiotic therapy response, the existence of a litter 
effect and the concurrence of other disease syndromes and well-known secondary 
pathogens may be features of immunosuppression in PMWS (Segales e t  a l . , 2004a).
PCV2 may also infect the boar. PCV2 DNA has been detected in seminal fluid 
and non-sperm cell fractions of boar semen samples. Therefore, semen may be a 
significant vehicle for the transmission of PCV2. Production of high quality pathogen 
free semen is of particular importance to artificial insemination (AI) organizations within 
the pig industry (Chae, 2005).
1.6 Porcine C ircovirus D isease (PCVD)
Since the identification of PCV2 and its subsequent association with PMWS, 
PCV2 has been increasingly isolated from pigs with other clinical signs. The 
terminology porcine circovirus diseases (PCVD) has recently been proposed to replace 
existing acronyms (Allan e t  a l . , 2000d; Allan e t  a l . ,  2005). These clinical syndromes and 
diseases are divided into pre- and post-natal manifestations. In pre-natal disease PCV2 
infection is linked to reproductive failures whereas the post-natal signs of the disease in 
Europe, Asia and North America are predominately PMWS, porcine respiratory disease 
complex (PRDC) and porcine nephropathy syndrome (PDNS) (Chae, 2004). PCV2 is 
also thought to play a major role in proliferative and necrotizing pneumonia (PNP),
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congenital tremors, sow abortion and mortality syndrome (SAMS), granulomatous 
enteritis, exudative epidermitis and necrotizing lymphadenitis (O'Connor et al., 2001; 
JungHyun et al., 2004). PMWS, PDNS and reproductive disorders are the most 
important ones. However, the extent of the involvement of PCV2 in pig diseases other 
than PMWS is still not clear as this virus is ubiquitous.
1.6.1 Reproductive Disorders
There have been several reports of PCV2 associated reproductive failure under 
field conditions and experimental studies have demonstrated a deleterious effect on 
foetuses when PCV2 has been directly inoculated into them (Sanchez et al., 2001b; 
Johnson et al., 2002; Sanchez et al., 2003; Pensaert et al., 2004b; Sanchez et al., 2004; 
Yoon et al., 2004). PCV2 can infect the foetus and cause reproductive failure in the 
absence or presence of other well established reproductive pathogens. Consistent clinical 
signs on affected farms include elevated levels of abortion, stillbirths and foetal 
mummification. Reproductive failure is characterised by late-term abortion and delivery 
of stillborn near-term foetuses or premature piglets. Detection of PCV2 antigen and 
nucleic acid in stillborn piglets suggests that PCV2 can be present in large amounts in 
foetuses infected in utero, indicating that vertical infection may be an important means of 
viral transmission. This mode of transmission could be related not only to reproductive 
failure but also to the development of multisystemic disease in later life. Almost all 
descriptions of reproductive disorders associated with PCV2 are from North-America 
(O'Connor et al., 2001), and very few cases have been reported in Europe (West et al., 
1999; O'Connor et al., 2001).
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Histopathologically there are no characteristic lesions in PCV2-infected aborted 
foetuses. Microscopic lung lesions have been reported in aborted foetuses in late 
gestation and stillborn piglets. When present, these lesions were mutifocal and mild to 
moderate in severity. Extensive areas of myocardial degeneration or necrosis, with 
oedema and mild fibrosis as well as a diffuse moderate infiltration of lymphocytes and 
macrophages, were observed (Segales et al., 2004a; Chae, 2005). The primary PCV2 
associated lesion in aborted or weak piglets appears to be myocarditis and PCV2 
infection alone can produce severe lesions. It has been confirmed that PCV2 is 
associated with failure at all stages of gestation (Sanchez et al., 2001a). The 
consequences of maternal infection at various stages of gestation may reflect the ability 
of the conceptus to support PCV2 replication rather than the effectiveness of the placental 
barrier (Chae, 2005; Ellis et al., 2004; Harding, 2004; Kim J., 2004; Pensaert et al., 
2004a; Segales et al., 2004a).
1.6.2 Porcine Dermatitis and Nephropathy Syndrome (PDNS)
PDNS is a relatively new and often fatal disease that primarily affects recently 
weaned and feeder pigs from 1.5 to 4 months of age. The syndrome was first recognised 
in the UK in 1993 (Smith et al., 1993). Since then it has been reported in several 
countries including Korea, Canada and the USA (Chae, 2005). PDNS is generally 
sporadic. The most common clinical signs are the development of round irregular 
shaped, red to purple skin lesions that coalesce to larger patches and plaques. Primary 
lesions in the skin and kidney are associated with a multisystemic vasculitis and skin 
lesions are usually first noted in the hindquarters, limbs and abdomen but may progress to
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involve the thorax, flank or ears. Shortly after the appearance of the skin lesions, pigs 
may become pyrexic with rectal temperatures greater than 41°C. The kidneys become 
enlarged, pale and often exhibit petechial haemorrhages. These lesions are probably the 
result of immune disease complex. Renal and inguinal lymph nodes are usually enlarged 
and haemorrhagic. In fatal cases, cutaneous lesions result from severe necrotizing 
vasculitis affecting the dermis and subcutis, characterized by leukocytoclastic (the 
presence of neutrophils with nuclear fragments) inflammation involving capillaries, small 
and medium sized venules and arterioles, accompanied by epidermal necrosis and 
ulceration and dermal haemorrhage. Mildly affected animals may remain afebrile, bright 
and alert and most often recover. Severely affected animals may demonstrate lameness, 
anorexia or weight loss. Sudden death may occur but this is rare. There is increasing 
evidence to support a link between PDNS and PCV2. PCV2 antigen and/or nucleic acid 
have been found in tissues of pigs with PDNS. Many herds in both Europe and Korea 
have reported PMWS and PDNS outbreaks occurring simultaneously or in close 
chronology. However, there appears to be no direct relationship between PMWS and 
PDNS in affected herds. Pigs with PMWS do not progress to PDNS and vice versa. 
PCV2 nucleic acid has been demonstrated in more abundance in lymph nodes from pigs 
with PMWS than in those from pigs with PDNS. In contrast, PCV2 nucleic acid was in 
more abundant in the kidney from pigs with PDNS than in those with PMWS. It is 
possible that the difference in distribution of PCV2 between PMWS and PDNS could be 
due to different tissue tropism of different PCV2 strains. There is also evidence that the 
presence of other pathogens, such as Pasteurella multocida or combinations of pathogens
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such as PCV2 and PRRSV may also induce PDNS (Chae, 2005; Ellis et al., 2004; 
Harding, 2004)
1.7 Clinical and Post-Mortem Findings
PMWS primarily occurs in pigs between 25 and 120 days of age, with most cases 
occurring between 8 - 1 2  weeks. Outbreaks are now being increasingly reported in 
fattening pigs (Allan et al., 2005). PMWS has been described in almost all types of 
farms, including farrow-to-finish and multi-site operations, and in sizes from 30 to 
10,000 sow herds. Clinical expression of the disease is associated with the generation 
and accumulation of infectious virus in target tissues. Morbidity and mortality are 
variable, depending on the farm and on the batches of animals and the stage of the 
outbreak, co-infections and husbandry and management within affected areas; the usual 
rates are 4 -  30% and 70 -  80% respectively (Segales and Domingo, 2002). Single pigs 
suffering from PMWS has also been observed sporadically on farms with very good 
production records and minimal postweaning mortality (Allan et al., 2005).
There are six fundamental clinical signs of PMWS, which may be non-specific 
and variable and form the basis of a preliminary clinical diagnosis (Segales and 
Domingo, 2002). The main clinical sign is wasting but it is usually seen concomitantly 
with other fundamental clinical signs such as, dyspnoea, enlarged lymph nodes (mainly 
inguinal superficial lymph nodes), diarrhoea, jaundice and pallor (Segales and Domingo, 
2002). Not all of the clinical signs may be present in a single pig; however, an affected
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farm will present the majority over a period of time. Other clinical signs noted include 
coughing, pyrexia, icterus, gastric ulceration, meningitis while sudden death may arise 
due to secondary infections (Segales and Domingo, 2002).
Although PMWS was first recognized in an SPF herd, additional infections or 
diseases are more commonly found in farms experiencing PMWS when compared to 
non-affected farms (Ellis et al., 2004). It has been reported that pigs suffering from the 
disease may become immunosuppressed, resulting in an increased susceptibility to other 
pathogens including bacteria and less frequently viruses, mycoplasma and protozoa (Ellis 
et al., 2000). Other viral and bacterial pathogens commonly found include, PRRSV, 
swine influenza virus (SIV), ADV, PPV Haemophilus parasuis, Actinobacillus 
pleuropneumoniae, Streptococcus suis, and Mycoplasma hyopneumonia, (Kim et al 
2002). Diseases found with increased frequency include Glasser’s disease, salmonellosis, 
streptococcal meningitis, postweaning colibacillosis, non-specific diarrhoea and hepatosis 
dietetica (Kim et al 2002). Whether or not the increased disease load found on PMWS- 
affected farms is a consequence of PMWS and the associated immune dysfunction has 
yet to be determined. It is probable that the final clinical outcome observed on farms 
affected with PMWS is the sum of the effects of the various concurrent diseases (Allan et 
al., 2005).
It has been reported that, on some farms, most of the pigs developing PMWS 
correspond to a few litters, suggesting a potential “litter effect” (Madec et al., 2000) and 
other reports have shown that castrated male pigs are more susceptible to PMWS than
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females (Rodriguez-Arrioja et al., 2002; Allan et al., 2005). It has also been reported that 
pigs with lower birth and weaning weights and lighter pigs at the beginning of the 
fattening period, were more likely to develop PMWS (Allan et al., 2005).
At necropsy, pigs suffering from PMWS present a variety of macroscopic and 
microscopic findings. Necropsy findings are mainly poor body condition, moderate 
pallor of the skin and various degrees of muscle wasting. Gross lesions in pigs with 
PMWS may be quite variable. The most striking lesions are: (i) non-collapsed lungs with 
interstitial oedema and enlargement of lymph nodes (mainly superficial inguinal, 
submandibular, mesenteric and mediastinal). However these lesions are not always 
present, (ii) mild to moderate atrophic discoloured livers (hepatic interlobular connective 
tissue may be prominent in severe cases). In the most advanced cases, pigs may have a 
flaccid liver, reduced in size, with marked loss of hepatocytes, increased amount of 
fibrous tissue at the lobular margins, and inflammatory infiltrates through all the hepatic 
tissue (Krakowka et al., 2000; Rosell et al., 2000); (iii) pale grossly enlarged kidneys 
may appear semi-translucent and waxy due to oedema and multifocal white foci may also 
be present on kidney cortices; (iv) other findings include bronchopneumonia which may 
be detectable due to bacterial infections; gastric ulceration of pars oesophaga (not directly 
related to effect of PCV2) of the stomach and fluid filled thin walled intestines especially 
the ileum and spiral colon; the spleen may be moderately enlarged, firm and non­
congested on cut surface, and in the end stages of disease cachexia may develop (Segales 
and Domingo, 2002). Although gross lesions are uncommon in the pancreas, there may 
be multifocal atrophy or regeneration in acinar epithelium that is associated with
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interstitial lymphohistiocytic infiltration. Other organs such as gastric and intestinal 
mucosa, heart, adrenal glands, salivary glands and bone marrow may also show foci of 
lympho-histiocytic inflammatory infiltrates, although in a lesser intensity and smaller 
distribution than the main affected organs mentioned. Histologic lesions are 
characterized by the presence of syncytial multinucleated giant cells in lymph nodes, 
liver, spleen, tonsil, thymus and Peyers patches and grape-like circoviral intracytoplasmic 
inclusion bodies within the multisystemic lesions (Kim J et al, 2001). Usually 
intranuclear PCV2 antigen is found in affected tubular epithelial cells and scattered in 
mononuclear phagocytes (Allan and Ellis, 2000a).
The histopathological lymphoid lesions observed in PMWS affected farms are 
unique (Clark, 1997; Rosell et al., 1999). Early microscopic lesions consist of infiltration 
of subcapsular sinuses by large histiocytic cells and giant multinucleate cells, and 
effacing of lymph follicles. Multinucleate giant cells may also appear in lymph follicles 
and in parafollicular zones. This is followed by depletion of lymphocytes in 
parafollicular zones, which vary in intensity from slight to intense (Clark, 1997; Rosell et 
al., 1999). In the thymus, cortical atrophy is a prominent finding (Darwich et al., 2003b). 
In a large number of cases it is possible to find cytoplasmic inclusions in histiocytes or 
dentritic cells. Inclusions are basophilic or amphophilic, rounded, and of very different 
sizes. Final stages of depletion show an empty lymphoid tissue, with a prominent 
network of stromal and accessory cells.
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From a clinical point of view the diagnosis of PMWS is difficult with clinical signs 
in each farm varying considerably. Diagnosis is generally based on clinical signs, post­
mortem changes, histopathology and PCV2 antigen and/or nucleic acid detection. 
However, a pig or a group of pigs is considered to suffer from PMWS if they meet the 
following criteria: (i) clinical signs including growth retardation and wasting, frequently 
with dyspnoea and enlargement of lymph nodes, and occasionally jaundice, (ii) presence 
of characteristic histopathological lesions in lymphoid tissues (lymphocyte depletion 
together with granulomatous inflammation) and presence of PCV2 inclusion bodies in a 
proportion of infected pigs, and (iii) detection of PCV2 within the lesions in lymphoid 
tissues of affected pigs. In all PMWS cases, PCV2 is present in a variable amount in at 
least one tissue of the affected pig. However, in order to detect PCV2 and other 
concomitant infections a wide range of tissues including lymph nodes, tonsil, spleen, 
intestines, lung, liver and kidney should be tested (Allan, 2002a; Segales and Domingo, 
2002).
In order to establish the aetiological diagnosis of PMWS, diagnostic techniques are 
required that link the presence of virus with tissue lesions. Several methods have been 
developed to detect PCV2 in tissues and to correlate its detection with the presence of 
lesions. Histopathology, together with a technique to demonstrate PCV2 levels, has been 
the most important tool to establish a diagnosis of PMWS. The most powerful 
combination is one that allows the correlation between the severity of histopathological 
lesions in lymphoid tissues and the amount of PCV2 in the same tissues. A clinical
1.8 D iagnosis
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diagnosis may therefore be confirmed using a combination of immunohistochemistry 
(IHC) and/or indirect fluorescent antibody (IFA) (Racine et al., 2004) or in situ 
hybridization (ISH) (McNeilly et al., 1999; Rosell et al., 1999; Choi and Chae, 2000; 
Kim and Chae, 2001) together with histopathology. Other techniques that may be used to 
detect PCV2 for diagnostic and research purposes include virus isolation (Allan et al., 
1998b), PCR (classical, multiplex or real-time), electron microscopy and DNA probes. 
Detection of PCV2 by virus isolation and PCR does not necessarily confirm a diagnosis 
of PMWS because PCV2 can be at a high concentration in healthy pigs. Information 
provided by IHC and ISH is more specific than that obtained by PCR as these methods 
provide cellular localisation and an indication of the level of expression of specific viral 
genes in tissue sections (JungHyun and ChanHee, 2004). Several serological techniques 
to detect antibodies to PCV2 have also been developed. These techniques are usually 
based on cell cultures infected with PCV2 and include indirect peroxidase monolayer 
assay (IPMA) (Mesu et al., 2000). A commercial enzyme linked immunosorbent assay 
(ELISA) has recently become commercially available from Synbiotics. Two new ELISA 
kits have been manufactured, SERELISA® PCV2 Antibody (Ab) Mono Blocking for use 
on serum and faeces samples, this kit uses a single well blocking immunoenzymatic 
technique and SERELISA® Ag Capture for use on faeces samples this kit uses a single 
well sandwich immunoenzymatic technique for the detection of PCV2 antigen. Wells are 
sensitized with anti-PCV2 Ab, viral protein if present binds to the specific sites an anti- 
PCV2 preoxidase conjugate allows the revelation of the antigen, optical densities are 
recorded and used to determine the presence or absence of antigen as a function of 
threshold values.
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When high concentrations of virus are detected in the presence of histological 
changes the animal is considered positive for PMWS. If slight lymphoid lesions together 
with low amounts of PCV2 are the dominating findings there are three possible 
interpretations: (i) the pigs are suffering from a subclinical PCV2 infection, (ii) they may 
be only at the initial stages of PMWS and the lesions and the amount of PCV2 could 
become more severe after this initial phase, (iii) the animals may be in a convalescent 
period after suffering from PMWS (Allan, 2002; Segalés and Domingo, 2002). Since 
sub-clinical PCV2 infection with viremia occurs on almost all farms detection of PCV2 
antigen or nucleic acid in tissues from clinically healthy pigs, or in diseased pigs without 
clinical signs and gross lesions consistent with PMWS should be interpreted with caution 
(Rose et al., 2003).
The case definition of PMWS does not exclude the concomitant presence of other 
diseases, and it implies that neither clinical signs nor gross lesions observed in suspected 
PMWS affected pigs are sufficient to diagnose the disease, although they are indicative. 
A herd case definition for PMWS should include the occurrence of a clinical process, 
characterised mainly by wasting and mortality, in excess of the expected and/or historical 
level for each farm, and the establishment of individual diagnoses of the disease in a 
number of pigs. However, the herd case definition for PMWS has not been formerly 
established yet (Segales et al., 2003a; Allan et al., 2005).
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There is growing concern regarding PMWS and why this disease has gone from a 
sporadic, low incidence occurrence to an epidemic form. It has been hypothesized that 
husbandry and management practices may have contributed to this change. A profound 
change has been observed in pig production structure and techniques as a result of 
competitive economic pressures. The size of herds has dramatically increased with 
obvious changes in nutrition, housing, herd management, prophylaxes and general 
hygiene routines. However, this intensification of European pig production has brought 
with it a particular set of problems at the post-weaning stage of production. There are 
four golden rules set out to limit the spread of PMWS in farms. These are as follows: (i) 
Limit pig-pig contact; (ii) avoid stress; (iii) Good hygiene; and (iv) Good nutrition 
(Krakowka et al., 2003).
Krakowka et al (2003) has postulated that the main risk factors associated with 
this disease are poor hygiene status in the post-weaning room, creep feed intake per piglet 
in the last week prior to weaning of less than 470g, draughts and poor air quality 
throughout the four weeks after weaning, poor weaning temperature and overcrowding. 
In addition, Krakowka et al (2003) has suggested that the water supply must be potable 
and within easy access, the number of piglets per pen should be less than 13, the number 
of litters of origin per pen should be less than 4 and to avoid commingled pigs of 
different age groups, in order to improve the severity of concurrent respiratory disorders 
and the overall farm disease level (Krakowka et al., 2003).
1.9 Possible R isk  F ac to rs fo r the O ccurrence  o f PM W S
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Because PCV2 is ubiquitous, minimal efforts have been applied to control the 
infection. Effective control measures for PMWS have focused on the understanding, 
control and eradication of infectious/non-infectious factors/triggers on individual farms. 
Management measures, nutrition, the effect of concurrent viral infections, stimulation of 
the immune system, serum therapy, PCV2 vaccination and the infectious PCV2 status 
and the antibody titres to PCV2 of the sow at farrowing (Allan et al., 2005; Marco, 2005) 
should all be monitored.
1.9.1 Management Practices
It has been suggested that several environmental factors might be necessary, in 
association with PCV2 infection, to lead to the clinical expression of PMWS. The 
implementation of the 20 Madec Principles, a list of zootechnical measures to lower the 
impact of the disease, has resulted in a reduction in post-weaning mortality (Madec,
2001). Madec’s points are not new and they are based on the strict use of all-in-all-out 
management, reduction of stress, keeping stocking densities to a minimum, and good 
hygiene. Sometimes it is difficult to fulfill all 20 points on all farms so it has been 
suggested that at least 16 of the 20  points should be achieved in order to see a response 
(Allan et al., 2005; Marco, 2005).
1.9.2 Nutrition
It has been reported that changes in the diet of PMWS-affected pigs has resulted 
in partial control of the disease (Donadeu et a l, 2004; Allan et al., 2005). Such changes 
included an increase in nutrient density for young pigs diet and addition of commercial
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feed additives with antioxidant effects, such as bioflavonoids, which are phytochemicals 
that act as antioxidants and have anti-inflammatory effects which may promote 
cardiovascular health (Allan et al., 2005; Marco, 2005). Another recent study has shown 
that conjugated linoleic acid (CLA) modifies PCV2 experimental infection (Bassaganya- 
Riera et al., 2003; Allan et al., 2005). It has also been suggested that addition of vitamin 
E and/or selenium because of their antioxidant properties to feed might be beneficial on 
farms with PMWS (Allan et al., 2005; Marco, 2005). Data from one farm in Denmark, 
however, showed no correlation between vitamin E levels in the blood of post weaning 
pigs and the outcome of PMWS (Baebko, 2004; Marco, 2005). However, there is not 
enough scientific information available to establish the full effect of nutrition on PMWS.
1.9.3 Effect of Concurrent Viral Infections
Viral co-infections have been used experimentally to reproduce PMWS as 
previously mentioned, and a wide range of infectious agents have been observed 
concomitant with PCV2 infection on PMWS affected farms (Segales and Domingo,
2002). Therefore, the control of these coinfectious agents in the post weaning area 
should decrease the incidence of PMWS.
1.9.4 Stimulation of the Immune System
The development of clinical disease following immunostimulation in PCV2 
experimentally infected pigs (Krakowka et al., 2001; Allan et al., 2005; Marco, 2005) has 
been supported by a number of on-farm studies where PCV2 infection and the use of 
certain commercially available vaccines or immunomodulators have acted as triggering
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factors for PMWS (Allan et al., 2001; Allan et al., 2005; Marco, 2005) suggesting that 
immune activation may be an important triggering factor of PMWS and perhaps the 
pivotal event in the pathogenesis of this disease on some farms. However, from a 
practical point of view it is not feasible to exclude the use of vaccines from sanitary 
programmes. However, producers with PMWS affected herds could re-schedule the 
timing of vaccination as a potential plan to minimize the disease (Allan et al., 2005).
1.10 Possible Treatments and Control Measures for PMWS-Affected 
Herds
1.10.1 Serum Therapy
Serum therapy has been shown to be useful in the control of PMWS (Marco, 
2005). It involves the subcutaneous injection of suckling or nursery pigs with PCV2 
hyperimmune sera from a commercial slaughterhouse (Ferreira, 2001; Waddilove, 2002; 
Allan et al., 2005). However, this technique has given variable results and its use in 
some farms did not result in any significant effect (Allan et al., 2005; Marco, 2005). 
Strict precautions must be applied when performing serum therapy. Blood collection 
must be from the same affected farm to reduce any risk of introducing other pathogens 
and collection and administration must be performed under strict conditions of hygiene. 
Serum kept frozen or serum from pigs that were already treated with serum when they 
were young leads to a reduction in its therapeutic properties (Allan et al., 2005; Marco, 
2005). The precise mechanism of action of serum therapy has not yet been elucidated
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(Allan et al., 2005). However, this technique has given variable results in different herds 
(Marco, 2005).
1.10.2 PCV2 Vaccination
Some experimental trials of vaccination have produced encouraging results. 
Vaccination with PCV2 proteins (ORF1 and ORF2) has shown a degree of protection. A 
more recent study using an inactivated vaccine in colostrum-deprived pigs challenged 
with PCV2 coinfection or previously immunostimulated, have shown a reduction in 
mortality (Marco, 2005).
An inactivated, ajuvanted PCV2 vaccine “Circovac” (MERIAL) for use in sows 
and gilts is now commercially available and in use under special license in some 
European countries and Canada. The efficacy of this vaccine in controlling PMWS under 
field conditions still remains to be elucidated (Allan et al., 2005).
1.10.3 PCV2 status and Serological Titres to PCV2 of the Farrowing Sow
It has been reported that active PCV2 infection or low serological titres to PCV2 
in sows at farrowing had a significant effect on the overall mortality of their offspring 
due to PMWS (Allan et al., 2002). The protective effect of passive maternal immunity 
on PMWS development is supported by the fact that disease occurs once these titres have 
declined (Rodriguez-Arrioja et al., 2002; Larochelle et al., 2003; Sibila et al., 2004). 
Therefore, measures that increase maternal immunity and decrease sow viremia at 
farrowing may diminish PMWS impact on piglet mortality (Allan et al., 2005).
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However, more recent studies in Denmark and the United Kingdom have shown that high 
levels of antibody to PCV2 in sows and gilts does not relate to any protection from 
PMWS in the piglets derived from these animals (Hassing et al., 2004).
1.10.4 Genetics
Field observations from farmers have suggested that certain genetic lines of pigs, 
specifically in relation to boar lines, are more susceptible to PMWS. However, there is 
very little data to support this (Allan et al., 2005; Marco, 2005). Recent experimental 
studies have shown that Landrace pigs were more susceptible to PMWS than Duroc and 
Large White Pigs (Opriessnig et al., 2004). However, other studies have shown 
contradictory results with the use of the Pietran boar line; as the use of this genetic boar 
line did not seem to have any effect on the offspring in one study (Rose et al., 2003). 
Another field study was carried out by Lopez-Soria et al (2004) to compare the effect of 
three different boar lines on the outcome of general and PCV disease-associated PMWS 
and their off spring. Lopez-Soria et al., (2004) observed a significant effect on general 
postweaning and PMWS associated mortalities (Lopez-Soria et al., 2004). These 
findings need to be expanded in an attempt to identify a possible combined 
epidemiologic, genetic and immunologic approach to the control of this disease (Darwich 
et al., 2004).
There are many control measures that can be used with regard to PMWS. These 
can be combined successfully. However, there is no general protocol that will suit all
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farms. Each individual farm will need to take a slightly different approach depending on 
their facilities, health status, genetics, etc.
1.11 PMWS in Ireland
1.11.1 PMWS in the Republic of Ireland
In 1998 an outbreak of ill-thrift and increase in mortality in pigs of five to six 
weeks of age, on an integrated 300-sow unit with a weaning age of approximately 26 
days was investigated by Spillane et al., (1998). The first signs noted included increase 
in mortality from 1.5 to 8% in the affected age group and respiratory disease in 20% of 
pigs characterised by an increase in coughing, sneezing and/or dyspnoea. Gross mortem 
examinations revealed lesions of pleurisy and pneumonia suggestive of Mycoplasma 
hyopneumonia and Pasteurella multocida infection. Histopathological examination of 
the liver from one affected pig revealed severe hepatic necrosis and histiocytic 
infiltration. Multifocal lesions of granulomatous inflammation were seen in the pancreas 
and kidney of this animal and there was severe lymphoid depletion and histiocytic 
infiltration of periarteriolar lymphoid sheaths in the spleen. Amphophilic 
intracytoplasmic inclusion bodies were seen in the infiltrated histiocytes. The 
histopathological lesions in this pig were similar to those of PMWS (Ellis et al., 1998) 
and the results of immunoperoxidase staining (Allan et al., 1998b) and the PCR 
technique indicated infection with PCV2. This was the first known report of PMWS and 
clinical PCV2 infection in the Republic of Ireland (Spillane et al., 1998).
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By the year 2000 PMWS had been diagnosed by Spillane in 7 herds since the 
original diagnoses in 1998 and PCV2 was identified in tissues of affected pigs from each 
herd. There was no localised geographic distribution of affected pig herds (Spillane, 
2000).
1.11.2 PMWS in Northern Ireland
In Northern Ireland an 11 week old pig was submitted for post-mortem 
examination in October 1997 from a herd with a history of sudden death; this was the 
first report of infection of pigs with PCV2 and associated PMWS-like lesions in pigs in 
NI and the British Isles (Kennedy et al., 1998). Histopathological examination revealed 
mild lymphoid depletion and the presence of synctia in mesenteric lymph nodes of this 
animal. In November 1997 a 12 week old pig was submitted for PM examination from a 
herd in which there was evidence of ill-thrift in young pigs and respiratory disease in 
finishing pigs, this was the second reported case of PMWS in this country. Enteritis and 
moderate lesions of pneumonia were seen at post mortem and histopathological 
examination revealed severe mononuclear cell infiltration and formation of syncytia in 
the lamina propria of the small intestine. Moderate lymphoid depletion, histiocytic 
infiltration and syncytia were seen in the mesenteric lymph nodes. Lesions of 
bronchointerstitial pneumonia were also apparent. Immunohistochemical staining 
revealed that lymphoid lesions were associated with a large amount of PCV2 antigen 
(Kennedy et al., 1998). The disease was not seen again until March 1999 when a 
diagnosis was confirmed on a different farm. This outbreak was associated at the time 
with the introduction of a new vaccination regimen for Mycoplasma hyopneumonia.
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Following this sporadic outbreak the disease was not seen to emerge again until 2002 
when a devastating outbreak with losses of up to 50% occurred on a farm in South 
Armagh. This disease outbreak was associated with importation of weaners from a 
PMWS affected farm in the ROI. From 2002 onwards, a total of 40 outbreaks of the 
disease have been recorded throughout NI, with losses ranging between 5 and 40% (Allan 
et al., 2005).
To date no pattern of spread of this disease within NI or the ROI has been 
demonstrated nor has any linkage been demonstrated in NI between specific pig breeders 
and outbreaks of disease (Allan et al., 2005).
1.12 Objectives for this Study
Since its occurrence PMWS has been reported in America, Europe, Asia and New 
Zealand. There was therefore a need to establish the current status of this viral disease on 
the island of Ireland. This project therefore was carried out as a collaborative project 
between Northern Ireland and Republic of Ireland. It was necessary to transfer 
techniques already used in Veterinary Sciences Division (VSD), NI to the Central 
Veterinary Research laboratory (CVRL), ROI so that an accurate diagnosis of PMWS 
could be achieved in the Republic of Ireland. An incidence study of suspect PMWS 
outbreaks was performed to determine the presence and emergence of PCV2 infection 
and associated disease in the pig population of Ireland. A serological survey was also 
carried out to determine the extent of PCV2 infection in Ireland. This was achieved by
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testing a percentage of random serum samples spread throughout the country for 
antibodies to PCV2. To determine if  different strains of the virus existed in Ireland it was 
necessary to isolate and type PCV2 strains from diseased and non-diseased pigs in 
Ireland. Detailed longitudinal studies on PCV2 associated diseased and non-diseased 
herds in Ireland were carried out in an attempt to elucidate any infectious/non-infectious 
“triggers” that may lead to PMWS.
Studies are on going on an all Ireland basis to try and identify any common 
factors or co-factors that could explain the epidemiology of the disease in Ireland.
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Chapter 2: Materials and Methods
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An immunoperoxidase monolayer assay (IPMA) for the determination of PCV2 
antibody titres in sera was performed as previously described (Allan et al., 2000c; 
Blanchard et al., 2003). This technique is based on cell cultures infected with PCV2. 
PCV-free PK15 cells grown at 37°C in 10% CO2 in minimal essential medium (MEM) 
(Biosciences, Dublin, Ireland) with Earls salts supplemented with 5% foetal calf serum 
(FCS) and lOOpg/ml gentamicin, were dispersed from confluent flasks using trypsin. The 
cells were resuspended in Hanks balanced salt solution (HBSS) without phenol red 
(Biosciences, Dublin, Ireland, Gibco cat. no. 14065-031) containing 1% FCS. To the cell 
suspension PCV2 was added and incubated on a roller with continuous mixing for 2-4 
hours, at 37°C. The cells were gently pelleted at 805 X g  for 5 minutes and resuspended 
in 300-mM D(+)-glucosamine (C6H13NO5 HC1, Sigma-Aldrich cat. no. G4875) prepared 
in HBSS. This suspension was incubated at 37°C for a further 10 minutes with 
continuous mixing. D-glucosamine (Sigma-Aldrich, Dublin, Ireland) stimulates the 
progression of cells in the S phase of mitosis, which accelerates the replication of PCV2 
(Tischer et al., 1987). However, care must be taken when carrying out this step due to its 
high level of cellular toxicity, and once the cells have been treated all traces of the 
glucosamine must be removed. The cells were then pelleted again as before and 
resusupended in MEM growth medium. The cells were resuspended at a concentration, 
which gave a near confluent monolayer within 72 hours of seeding the microtitre plates. 
The plates were harvested by removing the supernatant and washing the monolayer once 
with phosphate buffered saline and then leaving them to air dry completely. They were
2.1 Im m unoperoxidase  M onolayer Assay (IPM A)
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then sealed and stored at least overnight at -20°C prior to use in order to adhere cells to 
the plates.
In order to perform the antibody titrations the plates were removed from the 
freezer and allowed to come to room temperature and to completely dry. A 4% 
paraformaldehyde (PFA) (Sigma-Aldrich) solution in distilled water was added to each 
well for approximately 10  minutes in order to fix the cells followed by methanol 
containing 0.3% hydrogen peroxide for five minutes to destroy endogenous peroxidase. 
Serum dilutions from 1 in 50 to 1 in 156,250 were prepared in PBS containing 0.05% 
Tween 80 and 10% horse serum (PBS-TH) and 50|xl of each dilution was added to the 
wells of the seeded microtitre plates and incubated for one hour at 37°C. 50pl of a 1 in 
200 dilution of Peroxidase-conjugated rabbit anti-swine immunoglobulins (DAKO 
Cytomation Ltd. P0164) was added to each well and incubated for a further hour at 37°C. 
Finally, 50(4.1 enzyme substrate chromagen (AEC Zymed cat. no. 00-2007) was added to 
the plates and incubated at room temperature in the dark for 15 minutes. The reaction 
was stopped by washing the plates four times with distilled water. Finally, 10 0 (4.1 of 
distilled water was then added to each well prior to viewing under the microscope. 
Antibody reacting with PCV2-infected cells was seen as red coloured staining, 
predominantly in the cell nucleus. The titre was determined as the last dilution at which 
staining was still visible. All tests contained a positive control of known titre (provided 
by Veterinary Sciences Division, DARDNI, Stromont, Belfast), the test being valid if the 
results fell within a 2 -fold dilution of this known titre.
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2.2 Indirect Flourescent Antibody Staining of Pig Cryostat Tissue 
Sections for PCV2
In order to detect the presence of PCV2 antigen in fresh tissue samples, an IFA 
was performed, as previously described (Allan et al., 1994b), on snap frozen cryostat 
tissue sections. Fresh tissue samples were first frozen in isopentane cooled in liquid 
nitrogen. Frozen tissues were then stored at -20°C until required for sectioning. These 
sections were cut to 6(J,m onto clean glass slides in a cryostat set at -16°C. Tissue 
sections were treated with PCV2-specific monoclonal antibody F217 (1 in 100 dilution in 
0.01M PBS pH 7.2; (McNeilly et al., 2001) and incubated for one hour at 37°C followed 
by rabbit anti-mouse FITC (DAKO F216), 1 in 100 diluted in 0.01M PBS pH 7.2, 
containing 10% PCV2 antibody free normal pig serum for a further hour at 37°C. Slides 
were examined using x40 objective lens, using incident UV illumination. Scoring ranged 
from a negative to a +4. Where no fluorescence was observed the tissue was considered 
negative, slight to moderate fluorescing, tissues were scored 1+ and 2+, respectively. 
Tissues where most areas or all were fluorescing were scored 3+ and 4+ and were 
considered to be from a PMWS diseased animal.
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Various pig tissue samples (lymph nodes, liver, spleen, lung etc.), faeces and sera 
collected from pigs with and without PMWS, as confirmed by IFA, IHC and IPMA, were 
used. Viral DNA was extracted using the Qiagen DNeasy Tissue Kit (Qiagen, cat. no. 
69506) and QIAmp DNA Blood Mini Kit (Qiagen, cat. no. 51106), respectively, as per 
manufacturer’s instructions. Extracted products were then stored at -20°C until required. 
PCR primer pairs were selected from work published by Fenaux et al., (2000). These 
primers were reported to amplify two overlapping fragments representing the entire 
genome of PCV2. The first set of primers, CV1 and CV2, amplified a 989-bp fragment, 
and the second set of primers, CV3 and CV4 amplified a 1,092-bp fragment.
CV1: 5 ’ -AGGGCTGTGGCCTTTGTTAC-3 ’
CV2: 5’-TCTTCCAATCACGCTTCTGC-3’
CV3: 5’-TGGTGACCGTTGCAGAGCAG-3 ’
CV4: 5’-TGGGCGGTGGACATGATGAG-3’
PCR reactions were prepared as follows using HotStarTaq® PCR Kit (Qiagen, cat. no. 
203203):
2.3 Polym erase C hain  R eaction (PCR)
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PCR Mastermix:
PCR Component Volume (jj.1)
lOx Buffer 5.0
25 mM MgCl2 1.5
DNTP mix (lOmM) 8.0
Rnase/Dnase free H2O 28.0
Taq DNA polymerase 0.5
Primer 1 1.0
Primer 2 1.0
DNA Sample 5.0
Amplification reactions were performed in the DNA Engine PTC-200 as follows:
35 cycles of denaturation at 94°C for 1 minute, annealing at 55°C for 1 minute, and 
extension at 72°C for 3 minutes, followed by a terminal extension at 72°C for 7 minutes. 
This annealing temperature was 51°C for primer pairs CV1 and CV2. All PCR products 
were visualised by electrophoresis on a 2% high resolution agarose gel. PCR products of 
expected size were cleaned using QIAquick PCR Purification Kit (Qiagen, cat. no. 
28104) according to manufacturer’s instructions and were sequenced by MWG Biotech 
(Ebersberg, Germany). The sequences were then analyzed using the internet based bio- 
informatic software http://www.ebi.ac.uk/services/.
Analyzed sequenced products were found to not always overlap at expected 
regions, indicating that the entire genome had not been sequenced. Primer pairs were
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then designed in order to amplify the area of the genome where the original primer pairs 
did not overlap using the internet based software http://bibiserv.techfak.uni-bielefeld.de. 
These primers pairs were called CV5, CV6, CV7 and CV8 and each amplified a 600-bp 
fragment (figure 2.1).
CV5: 5’-GAGGAAGGACGAACACCTCAC-3’
CV6: 5’-GAGAGCTTCTACAGCTGGGAC-3 ’
CV7: 5 ’ -GAACAATCCACGGAGGAAGGG-3 ’
CV8: 5’-TGGGCGGTGGACATGATGAG-3’
PCR reactions were carried out as above.
PCR product 
CV7 and CV8
PCR product
CV5 and CV6
Figure 2.1: Genome of PCV2. Overlapping PCR fragments used to determine the
complete genome of PCV2 are indicated in the circular map.
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Immunohistochemistry was carried out in order to detect the level of PCV2 
antigen on tissue sections stored in 10% Neutral Buffered Formalin (NBF). The tissue 
sections were first dewaxed in two xylene baths for five minutes in each bath followed by 
two baths of methanol for five minutes each bath. Endogenous peroxidase was blocked 
with 0.5% H2O2 in methanol for 20 minutes, then briefly washed in distilled water. Tissue 
sections were then washed twice for 10 minutes in triphosphate buffer solution (TBS) and 
were incubated in 0.05% Protease 14 (Protease 14-P5147 SIGMA) in TBS, for 15 
minutes at 37°C and briefly washed in distilled water. Sections were then washed twice 
for 10 minutes in TBS then incubated in 10% normal goat serum (Biotylinated goat anti­
mouse, streptavidin peroxidase conjugate, Zymed Histostain Mouse SP Kit Catalogue no. 
95-6543B) for 30 minutes. Sections were incubated in PCV monoclonal F217 at 1/250 in 
PBS overnight at room temperature. Following overnight incubation sections were 
washed twice for 10 minutes in TBS and incubated in biotylinated goat anti-mouse 
antibody for 30 minutes followed by washing twice for 10 minutes in TBS. Sections 
were then incubated in streptavidin peroxidase conjugate reagent for 30 minutes and 
washed twice for 10 minutes in TBS, incubated in DAB substrate chromagen for approx. 
5 minutes and washed in distilled water. Sections were then counterstained with 
haematoxylin, cleared, mounted and examined by bright light microscopy. Scoring of 
sections for PCV2 antigen ranges from negative to a +4. A tissue score equal or greater 
than 3+ suggested the presence of PMWS (Ellis et al., 1998; McNeilly et al., 1999).
2.4 Im m unohistochem istry
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2.5.1 Sampling the herd
Two PMWS-affected and one non-affected control herd were identified and 
studied in ROI and one positive herd in NI. A full history was taken from each. 
Approximately 5 litters per herd were identified and tagged on the first week of life and 
used for the study. Immediatley after farrowing the sows were also bled and a serum 
sample stored. The piglets were raised “normally” and blood sampled approximately 
every 10 days. Sera were collected on a total of 7 sampling dates.
Samples taken from the piglets included clotted blood, tonsil and faecal swabs in 
viral transport medium (VTM) for virus isolation studies and a bacterial faecal swab in 
Aimes charcoal transport medium.
On arrival at the laboratory, blood samples were centrifuged at 805 X g  for 10 
minutes and the serum removed. Sera were then tested to determine PCV2 antibody titre 
(IPMA) and the presence of antibodies to PPV by ELISA. All sera were stored at -20°C 
until required. A cohort of approximately 20 serum samples was chosen from each farm 
for anlaysis, this cohort included any animals, which had died during the study and a 
selection of animals from each litter and pen.
Faecal and tonsil swabs in VTM were vortexed and stored frozen at -70°C on the 
day of sampling. After all samples from each herd were collected a cohort of samples 
was then chosen. This cohort was chosen at random, including all pigs that had died
2.5 L ong itud inal Field Studies
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during the study and a number of healthy animals were chosen from each litter. These 
samples were then subjected to two freezc-thaw cycles, clarified by centrifugation at 805 
X g  for 30 minutes and the supernatant removed, aliquoted and stored frozen at -70°C 
prior to virus isolation studies. Faecal swabs collected using Transport swabs (Medical 
Supply Co. Ltd., Dublin, Ireland) containing Aimes Charcoal for bacteriology were tested 
for the isolation of heamolytic E. coil, Campylobacter spp. and Salmonella spp. 
immediately upon arrival in the laboratory.
2.5.2 Protocol for the Isolation o f Haemolytic E. coli from faecal swabs
McConkey agar (Oxoid, Hampshire, UK) and Blood Agar (Oxoid, Hampshire, 
UK) plates were prepared according to the manufacturers instructions. Faecal swabs 
were streaked directly onto McConkey plates. The plates were then incubated 
aerobically at 37°C overnight. Presumptive positive pink colonies were then restreaked 
onto blood agar plates and incubated aerobically at 37°C overnight. A zone of 
haemolysis surrounding the streak suggested the presence of haemolytic E.coli in the 
faecal swab. Colonies suggestive of haemolytic E. coli were stored on protecta beads 
(Technical Services Consultants Limited, England) and stored at -20°C for later species 
confirmation.
Three beads from each stored haemolytic suspect E. coli isolate were plated onto 
blood agar plates and incubated aerobically at 37°C overnight. A bacterial suspension 
was prepared in API NaCl 0.85% medium (Biomerieux, UK) and API 20E tests were 
carried out according to the manufacturers instructions in order to identify the culture.
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Modified charcoal cefoperazone deoxycholate agar (mCCDA) (Mast Preston 
blood-free agar DM251 containing one Camp “Selectavial” supplement SV 18/litre, Mast 
Diagnostics, Merseyside, U.K.) plates were prepared according to the manufacturer’s 
instructions. Addition of CCDA Selective Supplement inhibited growth of 
enterobacteriaceae, yeasts and fungi and made it more selective for C. jejuni, C. coli and 
C. lari. Faecal swabs were streaked onto CCDA plates to obtain single colonies. The 
plates were incubated at 42°C for 48 hours in a microaerophilic atmosphere of 
approximately 6% (v/v) O2, 7% (v/v) CO2, 7% (v/v) H2, 80% (v/v) N2. This was achieved 
using commercial catalyst-free gas generating kits (Genbox microaer gas packs, 
Biomerieux, U.K.). Presumptive Campylobacter colonies were defined as colonies 
which appeared grey and had a watery appearance. Ten persumptive Campylobacter 
colonies were subcultured onto blood agar and incubated microaerobically at 42°C for 48 
hours. The Biochemical tests to identify the species of Campylobacter were carried-out 
according to manufactures instructions (Camp ID™, Mast Diagnostics, Merseyside, 
England). This 3-test biochemical profiling system for the presumptive identification of 
thermophilic Campylobacter spp. was based on the detection of hippurate hydrolysis, 
indoxyl acetate hydrolysis and urease activity and is differentiates for C. jejuni, C. coli 
and C. lari.
2.5.3 P r o t o c o l  f o r  t h e  I s o l a t i o n  o f  C a m p y l o b a c t e r  s p p .
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2.5.4 Protocol for the Isolation o f Salmonella spp.
Faecal swabs were placed into sterile universal containers containing lOmls pre­
enrichment broth, Buffered Peptone Water (BPW) (Oxoid, U.K.) and incubated overnight 
at 37°C. Following incubation, 100fj,l of the pre-enrichment media containing the swab 
was transferred into lOmls of Rappaport-Vassiliadis Broth (RV) (Oxoid, U.K.) and 
incubated overnight at 42°C. Following incubation, cultures were streaked onto both 
modified Brillant Green Agar (BGA) (Oxoid, U.K.) and Mannitol Lysine Crystal Violet 
Blue Agar (MLCB) (Oxoid, U.K.) plates and incubated overnight at 37°C. Presumptive 
positive colonies were seen as red-pink-white opaque coloured colonies on the BGA 
plates and large purple black colonies of H2S positive Salmonellae or black “bulls-eye” 
colonies on MLCB plates. Confirmatory tests were applied to suspect colonies. Suspect 
colonies were streaked onto MacConkey plates and incubated overnight at 37°C. To 
determine if these colonies were poly ‘O’, positive samples were tested using Murex 
Salmonella Poly ‘O’ group A-G antiserum (Cruinn Diagnostics Ltd., Ireland) according 
to manufacturers instructions.
2.5.5 Virus Isolation from tonsil and faecal swabs
All virus isolation work was carried out on Primary Pig Kidney cells (PK-05). 
Freshly obtained trysinised PK-05 cells were grown at 37°C for 3 days in MEM, in a 5% 
CO2 atmosphere, until a semi-confluent growth of cells was visible, prior to inoculation 
with 100(4.1 of either tonsil or faecal VTM aliquots. Tubes were then incubated on rollers 
at 37°C for approximately 6 days. Cells were checked for cytopathic effect (CPE) 3, 4 
and 5 days following inoculation. Monolayers which had been completely lysed were
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immediately frozen. Cells which showed some or no CPE were subjected to freezing on 
day six and then frozen and thawed twice more prior to being passaged onto fresh 3 day 
old primary PK-05 cells and incubated at 37°C on rollers. The cells were again checked 
for CPE on days 3, 4 and 5 following incoulation. Following this passage, all cells 
showing viral CPE were passaged into 25ml flasks and incubated at 37°C for a further 
three days and then checked again for CPE on days 3, 4 and 5. At this stage all cells 
showing good CPE were checked by PCR for the presence of enteroviruses 1 and 2 
reovirus and adenoviruses.
2.5.6 Serum Analysis
2.5.6.1 Enzyme Linked Immunosorbent Assay (ELISA)
A commercially available ELISA, Svanovir™ (cat. no. 10-7400-02, Uppsala, 
Sweeden) for PPV Antibody was used to detect antibodies to PPV in serum. This test 
was carried out according to the manufacturers instructions. The kit consisted of 
microplate strips coated with non-infectious PPV antigen, positive and negative control 
sera, PBS-Tween solution, conjugate, TMB substrate chromagen and stop solution. The 
principle of the test is based on a competitive ELISA. In this procedure sera were reacted 
with noninfectious PPV antigen coated wells on microtitre strips. Serum samples, 
controls and the antibody conjugate were added simultaneously. PPV antibodies (if 
present) compete with the enzyme-conjugated antibodies for the antigen binding sites in 
the wells. In the absence of PPV antibodies the enzyme conjugated antibodies are bound, 
giving rise to a colour change when a substrate chromagen solution was subsequently 
added. Therefore, the absence of colour indicated a positive result. The optical density
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(OD) was measured at 450nm and mean OD values were calculated for each of the 
controls and sera samples. The percent inhibition (PI) values for controls as well as sera 
samples was calculated using the following formula:
PI= 100 — (Mean OD samnles/cnntrol X 100)
Mean OD negative control
A sample was regarded negative when PI < 50, positive when PI 50 -  80 and a strong 
positive when PI >80. To ensure validity of the test the negative control should have an 
OD value greater than 0.6 and the positive control should have an OD less than 0.3.
2.5.6.2 PC V2 Antibody Detection and Titration
The testing for PCV2 antibody titre was performed on a cohort of serum samples 
from each of the three herds by the IPMA method as described above, section 2.1.
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Chapter 3: Determination of the Presence and 
Extent of PCV2 Infection and Associated 
Disease in Pig Herds in Ireland
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A serological survey was performed to determine the extent of PCV2 infection in 
both parts of Ireland. Serum samples were tested using the IPMA method, this technique 
is based on PCV-free PK15 cell cultures infected with PCV2 virus. Ten serum samples 
from fifty randomly selected herds in the south of Ireland and ten to nineteen serum 
samples from 20 herds in the North of Ireland were tested. Of the 70 farms tested only 
four herds were negative for PCV2 antibody. These four negative herds were all small 
hobby herds (less than 12 pigs) from ROI. These findings indicate that there is 
widespread seroconversion to PCV2 in both parts of Ireland. There was a significant 
variation in PCV2 antibody titers from animal to animal within the same herd and from 
herd to herd.
To establish the current level of PMWS in Ireland a study was performed to 
determine the incidence of PMWS in both parts of Ireland over a 12 month period. Pig 
veterinarians were asked to submit tissue samples (lymph nodes, liver, spleen, kidney and 
lung) from four necropsied pigs from suspect herds. Suspect herds were identified as 
herds that showed clinical signs consistent with PMWS such as an increase in weaner 
mortality, wasting or ill-thrift, respiratory disease, jaundice, pallor and sudden death in 
weaned pigs (Segales and Domingo, 2002). A PMWS case was confirmed by testing 
with a combination of indirect fluorescent antibody staining of pig cryostat tissue sections 
and/or immunohistochemistry and histopathology. In some cases both IF A and IHC were 
performed in order to ensure the accuracy of results when determining PCV2 levels. This 
study ran from 01/01/2004 to the 31/12/2004. In this year there was a total of 30 suspect
3.1 A b strac t
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herds in the South of Ireland and 31 in the North of Ireland. All herds tested were 
positive for the presence of PCV2 antigen, however, of the 30 herds in the South of 
Ireland 24 had high PCV2 levels and histological lesions consistent with PMWS and 6 
had lower PCV2 levels, which were considered negative for PMWS. In the North of 
Ireland there was a total of 14 herds positive for PMWS and 17 herds negative based on 
PCV2 levels.
The results of this study indicate that PCV2 is widespread in Ireland and that new 
cases of PMWS are occurring throughout the island. Therefore PMWS is a significant 
economic and welfare risk to the Irish pig industry.
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Post Weaning Multisystemic Wasting Syndrome (PMWS) is a new and emerging 
disease in the pig industry worldwide (Chae, 2004). It was first described in western 
Canada in a specific pathogen free (SPF) herd in 1991 (Clark, 1997; Harding, 1997). 
PMWS has since spread throughout most of the world (except Australia). This syndrome 
has significant consequences for the pig industry worldwide from a welfare and economic 
viewpoint. It has been estimated that PMWS costs around €600 million per year to the 
European Union (Armstrong, 2004).
PMWS was first reported in Republic Ireland in 1998 (Spillane et al., 1998) and 
Northern Ireland in 1997 (Kennedy et al., 1998). An apparent increase in the number of 
PMWS cases in Irish pig herds as observed by veterinarians at the Central Veterinary 
Research Laboratory (CVRL) during 2003 prompted the present study to establish the 
current status of this disease in Ireland. To the author’s knowledge this is the first 
detailed report of the prevalence of PCV2 infection in pigs and the incidence of PMWS 
in the Republic of Ireland.
The main objectives of this study were (1) to estimate the prevalence of PCV2 
infection in Irish pigs by testing for the presence of antibody to PCV2 and (2) to provide 
laboratory confirmation of suspect clinical PMWS on submitted samples from notified 
suspect herds throughout the island of Ireland, by quantifying the amount of PCV2 
antigen present in tissues from affected pigs.
3.2 In tro d u c tio n
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3.3.1 Serological Survey to determine the Prevalence o f PCV2 Infection in Irish Pigs 
Sera were tested for the presence of PCV2-specific antibodies using the
immunoperoxidase monolayer assay (IPMA) as described in chapter two. Five-fold 
dilutions of each serum sample were performed (beginning with a lowest dilution of 1 in 
50 and ending with a highest dilution of 1 in 156,250). In Northern Ireland two-fold 
dilutions were used (beginning with an initial dilution of 1 in 50 and a final dilution of 1 
in 102,400). The antibody titre for each serum sample was the last dilution at which 
red/pink staining of cells was still visible. The mean titre was then calculated for each 
herd (as the average titre for all sera tested in that herd).
In the Republic of Ireland (21 of the 26 counties) 426 sera from 50 herds were 
chosen at random from 1149 registered pig herds. Up to ten sera were tested from each 
of these herds; sera were taken from pigs of different ages and from both breeding sows 
and fatteners. In Northern Ireland, 212 sera were collected from 20 herds; 10 sera were 
collected from 16 of the 20 herds, 11 sera from 3 herds and 19 sera from one herd; all of 
these sera were collected from fattener pigs that were randomly selected at slaughter.
3.3.2 Study o f PCV2 infected herds to establish the number of PMWS cases from 
submitted clinically suspect herds
This study was performed over a one-year period (01/01/2004 to 31/12/2004) in 
order to determine the extent of the disease in Ireland. It involved working on a 
collaborative basis with private veterinary practitioners (PVPs) and the regional
3.3 M ateria ls  and  M ethods
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veterinary laboratories (RVLs) of the Department of Agriculture and Food (DAF). In the 
case of each herd in which PMWS was suspected, the veterinarian investigating the herd 
was asked to perform a necropsy on at least four affected pigs and to submit tissues 
(lymph nodes, liver, spleen, kidney and lung) for laboratory analyses. Herds in which 
PMWS was suspected were those with persistent clinical disease and high mortality; 
clinical signs which were observed and are consistent with a diagnosis of PMWS 
included an increase in weaner mortality, wasting or ill-thrifl, respiratory disease, 
jaundice, pallor and sudden death in weaned pigs. The basis for the confirmation of 
PMWS was the diagnostic criteria reported from the meeting of the American 
Association of Swine Practitioners in Quebec (Canada) in March 1997; namely, (1) the 
existence of characteristic clinical signs, (2) the presence of characteristic microscopic 
lesions and (3) the detection of PCV2 within these lesions (Clark, 1997). Thus a clinical 
diagnosis of PMWS was confirmed in the laboratory using a combination of 
histopathology and either immunoflouresence assay (IFA) or immunohistochemistry 
(IHC) to demonstrate the presence of PCV2 antigen by immunological means as 
previously described in chapter 2. PCV2 virus has been present in pigs for many years 
prior to the recognition of PMWS (Staebler et al., 2005), without being associated with 
any specific disease syndrome and PCV2 antigen is now evident in tissues collected from 
most pigs. However, a pig was only confirmed as PMWS positive if high levels of PCV2 
antigen were displayed by immunological means and characteristic histopathalogical 
lesions were present. In some cases both tests were not performed, in this situation a 
diagnosis was made based on the result of the test used and the clinical signs observed. 
In a case where conflicting results arose between the two tests (i.e IFA was negative for
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PMWS and IHC positive or vice versa) a positive result was given as enough antigen was 
present on the tissue section to indicate the animal was PMWS positive.
3.4 Results
3.4.1 Serological Survey
3.4.1.1 Republic of Ireland
In the Republic of Ireland forty-six of the 50 sampled herds tested positive for 
antibodies to PCV2 (by IPMA). Of the 426 sera tested, 363 (85.2%) were antibody 
positive and 63 (15%) negative. The reciprocal mean titre varied considerably between 
herds, ranging from 230 to 88,550 (Table 3.1). There was also a wide variation in 
reciprocal antibody titres for the individual pigs within herds (Figure 3.1a and b). In 
most herds, at least eight of the ten pigs tested were sero-positive (Figure 3.2). All four 
sero-negative herds, accounting for 17 of the 63 sera that tested negative in this survey, 
were small “hobby” herds, each of which consisted of 12 pigs or less and were located in 
counties Clare, Kildare, Mayo and Westmeath.
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Number of positive animali per herd tested
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Figure 3.2: Number of PCV2 antibody-positive animals per herd in ROI
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Farm No. Type of Pig Sera +ve/ 
sera tested
Min Reciprocai 
Herd Titre
Max
Reciprocai 
Herd Titre
Arithmetic Mean 
Reciprocal Herd 
Titre
l Sows 8/10 250 6.250 1,300
2 Finishers 10/10 6,250 156,250 28.650
3 Sows 9/10 6,250 250 1,925
4 Fattener 10/10 6,250 156,250 48.575
5 Gilts/Sows/Fatteners 10/10 250 156,250 25,075
6 Fatteners 10/10 156.250 6.250 88,550
7 Gilts/Sows/Fatteners 9/10 0 31,250 9,075
8 Sow/Boar 0/2 0 0 0
9 Fatteners 10/10 1,250 156,250 48.075
10 Fatteners 8/10 0 156,250 22,465
11 Fatteners 10/10 156,250 6250 38.675
12 NA 2/3 0 1250 500
13 Fatteners/Sows 10/10 250 156.250 22.975
14 Stickler 10/10 50 250 230
15 Fatteners/Sows 8/10 0 156.250 19,650
16 Sows 0/1 0 0 0
17 Fatteners/Sows 10/10 250 156,250 20,400
18 Sows 10/10 6,250 156,250 38,550
19 Finishers 10/10 6,250 156,250 88,550
20 Sows 10/10 250 31,250 9,100
21 Fatteners 10/10 1,250 31,250 6.725
22 Sows 3/3 6,250 6,250 6,250
23 Sows/Finishers 10/10 250 156,250 21,500
24 Sows 10/10 250 6,250 4,550
25 NA 5/10 0 156,250 21.950
26 Fatteners/Sows 0/10 0 0 0
27 NA 1/1 0 31,250 250
28 Sows 9/10 250 250 8,575
29 NA 7/10 0 156,250 19.725
30 NA 10/10 250 156,250 26,550
31 Fatteners/Sows 10/10 31,250 50 6,605
32 NA 1/10 6,250 6,250 6,250
33 NA 9/10 0 6.250 2.425
34 NA 9/10 0 31,250 19,875
35 NA 10/10 1,250 156,250 64,750
36 Gilts 10/10 250 156,250 58,000
37 Sows 9/10 0 31,250 5,500
38 Finishers/Sows 8/11 0 6,250 1,727
39 Fatteners/Gilts 5/10 0 31,250 12.625
40 Finishers/Sows 9/10 0 6750 2.425
41 Fatteners/Sows 8/10 0 156,250 84,325
42 Sows 5/10 0 156250 22,550
43 Fatteners 0/2 0 0 0
44 Sows 8/10 0 31,250 8950
45 Sows 9/10 0 31 »250 13,025
46 Fatteners/Sows 5/10 0 156,250 17,100
47 Sows 3/10 0 31,250 3.350
48 Fatteners 10/10 1,250 250 950
49 NA 3/3 31,250 1.250 12,833.33
50 NA 3/3 31,250 250 20.750
Table 3.1: Serological Survey to Determine the Prevalence of PCV2 Infection in the
Republic of Ireland.
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Figure 3.1a: Maximum, Minimum and Mean Reciprocal Antibody Titre per Herd in
ROI herds 1 - 2 5
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Figure 3.1b: Maximum, Minimum and Mean Reciprocal Antibody Titre per Herd in
ROI herds 27-50.
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In Northern Ireland all of the sampled pigs were sero-positive for PCV2 
antibodies. The majority of herds displayed high antibody titres. Low antibody titres 
were only observed in one of the herds in which the reciprocal antibody titres ranged 
from 400 to 12,800 (Table 3.2). A wide variation in antibody titre was observed between 
individual animals in each herd (Figure 3.3).
3 . 4 . 1 . 2  N o r t h e r n  I r e l a n d
Farm
No.
Type of Pig Sera +ve 
sera tested
Min
reciprocai
Antibody
Titre
Max
reciprocai
Antibody
Titre
Arithmetic 
Mean reciprocal 
Antibody Titre
1 Fattener 10/10 6,400 102,400 45,440
2 Fattener 10/10 3,200 102,400 61,760
3 Fattener 10/10 1,600 51,200 25,120
4 Fattener 10/10 6,400 102,400 68,072
5 Fattener 10/10 51,200 102,400 88,436
6 Fattener 10/10 12,800 102,400 57,600
7 Fattener 10/10 51,200 102,400 87,040
8 Fattener 10/10 6,400 102,400 58,240
9 Fattener 10/10 6,400 102,400 39,680
10 Fattener 11/11 3,200 102,400 62,545
11 Fattener 10/10 800 102,400 41,360
12 Fattener 11/11 3,200 51,200 15,709
13 Fattener 11/11 800 102,400 35,418
14 Fattener 10/10 400 12,800 3,720
15 Fattener 10/10 51,200 102,400 97,280
16 Fattener 10/10 25,600 102,400 89,600
17 Fattener 10/10 51,200 102,400 92,160
18 Fattener 19/19 3,200 102,400 72,252
19 Fattener 10/10 3,200 51,200 21,760
20 Fattener 10/10 1,600 102,400 30,240
Table 3.2: Serological Survey to Determine the Prevalence of PCV2 Infection in
Northern Ireland.
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Figure 3.3: Maximum, Minimum and mean Reciprocal Antibody Titre per Herd in NI
herds.
3.4.2 Detection of PMWS In Ireland (North and South) front clinically suspect
PMWS cases
In the Republic of Ireland an average of four pigs from each of a total of 30 herds 
in which PMWS was suspected were submitted to the CVRL, DAF. Twenty-four (80%) 
of these herds were confirmed in the laboratory to have PMWS. An average of 4 pigs 
from 31 problem herds in Northern Ireland were submitted to the Veterinary Sciences 
Division (VSD), DARDNI as suspect PMWS cases; PMWS was confirmed as present in 
14 (45.2%) of these herds. IF A, IHC and histopatholoigcal findings from positive and 
negative herds in the ROI are shown (Tables 3.3) and IFA and histopathological results 
for NI (Table 3.4). The main clinical signs in the herds in which PMWS was confirmed 
included wasting, respiratory distress, increased mortality and diarrhoea, while the
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principal necropsy finding was lymph node enlargement (Table 3.5). Similar clinical and 
gross pathological findings were evident in herds in which PMWS was not confirmed in 
the laboratory. Mortality in positive herds (those which scored 3+ or 4+ by IFA and/or 
IHC) ranged from 2% to 19%, and in negative herds (those which scored a 0, 1+ or 2+ by 
IFA and IHC) from 6% to 20% in 5 to 14 week old pigs. The principal histopathological 
lesions observed in pigs from PMWS positive herds included lymphocytic depletion; 
histiocytic infiltration and the presence of giant cells in the lymph nodes; 
bronchointerstitial or bronchopneumonia featuring occasional syncytia and the presence 
of inclusion bodies in the lungs; pulmonary oedema and lymphohistiocytic interstitial 
nephritis and infiltrates of mononuclear cells in subcapsular and pelvic areas of kidney.
In Northern Ireland the clinical and necropsy findings were similar to those 
reported in the Republic of Ireland from positive PMWS herds (Table 3.6); mortality in 
affected herds ranged from 2% to 13%. The principal histopathological lesions in pigs 
from PMWS-affected herds was lymphocytic depletion in secondary lymphoid organs 
(lymph nodes, spleen and tonsil) and necrosis; aggregates of syncytial cells and typical 
PCV2 type inclusion bodies were prominent features in these lymphoid tissues. 
Interstitial pneumonia and bronchopneumonia were accompanied by interlobular and 
alveolar oedema. Interstitial renal oedema and focal lymphocytic interstitial nephritis 
were observed, as were cytoplasmic inclusion bodies typical of PCV2 infection. As can 
be seen from tables 3.3 and 3.4 herds with high levels of PCV2 antigen were also found 
to have histopathological lesions associated with PMWS showing a good correlation 
between the two tests.
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Farm
Reference
No.
No. of Animals 
Submitted 
to Laboratory
IFA1 IHC2 Histopathological
lesions
PMWS Herd 
Result
1 4 0/4 0/4 B, L Neg
2 4 0/4 NT NT Neg
3 4 1/4 3/4 L, I Pos
4 3 2/3 1/3 L Pos
5 2 0/2 1/2 L, G, I Pos
6 3 1/3 1/3 NT Pos
7 4 3/4 3/4 B, L Pos
8 6 5/6 5/6 NT Pos
9 3 2/3 2/3 B, G, M Pos
10 2 0/2 2/2 L. G. I. IN Pos
11 4 3/4 2/4 I Pos
12 6 5/6 NT NT Pos
13 3 2/3 3/3 B, L, G, I Pos
14 4 1/3 1/3 1,0 Pos
15 2 0/2 NT H Neg
16 1 1/1 NT NT Pos
17 6 3/6 3/6 I, G, L, O Pos
18 3 1/3 1/3 L, I, IB Pos
19 2 1/2 NT NT Pos
20 5 1/5 NT NT Pos
21 3 2/3 3/3 B, L, IN Pos
22 2 0/2 0/2 LN, H Neg
23 1 0/1 NT NT Neg
24 4 3/4 1/4 M, G, L Pos
25 2 2/2 1/2 I,L Pos
26 3 3/3 3/3 L, I, G Pos
27 3 0/3 0/3 I Neg
28 2 2/2 2/2 NT Pos
29 2 2/2 1/2 I, L, IN, Pos
30 1 NT 1/1 L, B Pos
1 = No. of animals which tested positive for PM WS by IFA over the number of animals tested by IFA in this herd.
2 = No. of animals which tested positive for PMWS by IHC over the number of animals tested by IHC in this herd.
NT= Not tested
NO = no significant abnormality 
L = lymphocytic depletion 
G = giant cells in lymph nodes 
I = interstitial pneumonia 
B = bronchopneumonia 
IN = interstitial nephritis 
O = oedema
M = mononuclear cells in pelvic areas of kidney 
H = hepatitis 
LN = Lythic necrosis 
IB = inclusion bodies
Table 3.3: Detection of PCV2 Antigen by FAT & IHC in PMWS-affected Herds in
the Republic of Ireland.
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Farm
Reference
No.
No. of 
Animals 
Submitted to 
Laboratory
IFA1 Histopathological
lesions
PMWS Herd 
Result
8 3 1/3 I, L, O, IB Pos
9 7 4/7 IB, LN Pos
10 4 0/4 I, O, B, L, IB Neg
11 1 1/1 L Pos
12 2 1/1 IB, B Pos
13 2 1/1 B, L Pos
14 4 1/2 I, O, IB, L, LN Pos
15 1 1/1 IN, L, IB Pos
16 2 1/2 L Pos
17 1 0/1 B Neg
18 2 0/2 IB Neg
19 1 0/1 B, O Neg
20 4 1/2 O Pos
21 1 0/1 NO Neg
22 5 2/5 B, IN, L Pos
23 1 0/1 B Neg
24 4 1/4 L, IB, L Pos
25 1 0/1 O, B Neg
26 4 0/4 IN, B Neg
27 2 0/2 B Neg
28 8 5/8 LN, L, IB, O, B Pos
30 2 0/2 O Neg
31 1 0/1 NO Neg
32 1 0/1 NT Neg
33 3 0/3 B, O, L Neg
34 1 0/1 L Neg
35 4 2/4 L, I Pos
37 5 0/1 NO Neg
38 1 0/1 H, I, IN Neg
39 3 0/1 Men Neg
46 1 1/1 L Pos
1 = No. of animals which tested positive for PM WS by 1FA over the number of animals tested by IFA in this herd.
NT = Not tested
NO = no significant abnormality 
L = lymphocytic depletion 
G = giant cells in lymph nodes 
I = interstitial pneumonia 
B = bronchopneumonia 
IN = interstitial nephritis 
O = oedema
M = mononuclear cells in pelvic areas of kidney
H = hepatitis
LN = Lythic necrosis
IB = inclusion bodies
Men = meningitis
Table 3.4: Detection of PCV2 Antigen by IFA in PMWS-Positive and Negative
Herds in NI.
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Positive Farms Negative Farms
Wasting 16/24 3/6
Jaundice 6/24
Respiratory Disease 14/24 3/6
Pallor 11/24 3/6
Lymph Node Enlargement 17/24 3/6
Diarrhoea 18/24 3/6
Pneumonia 12/24 3/6
Oedema 2/24 1/6
GIT Ulceration 1/24 2/6
Kidney Lesions 8/24 1/6
Sudden Death 1/24 1/6
Table 3.5: The Principal Clinical and Necropsy Findings Observed on Problem farms
in the Republic of Ireland.
Positive Farms Negative Farms
Wasting 14/14 9/17
Jaundice 1/14 1/17
Respiratory Disease 6/14 5/17
Pallor 6/17
Lymph Node Enlargement 9/14 6/17
Diarrhoea 11/14 3/17
Pneumonia 6/14 7/17
Oedema 3/14 8/17
GIT Ulceration
Kidney Lesions
Sudden Death
Table 3.6: The Principal Clinical and Necropsy Findings Observed on Problem farms
in Northern Ireland.
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In this study serum antibodies to PCV2 were found to be ubiquitous in Irish pigs, 
with 85% of herds testing sero-positive in Republic of Ireland and 100% testing sero­
positive in NI. These findings are consistent with previous reports elsewhere (Clark, 
1997; Sibila et al., 2004). Several separate studies have indicated that a high PCV2 
seroprevalence is a worldwide phemomenon (Segales and Domingo, 2002). In Sweden, 
two separate serological surveys found 96% and 81% of porcine sera to be positive for 
antibodies to PCV2 (Wallgren et al., 2004). A similar situation was observed in The 
Netherlands where 94% of Dutch pig herds were antibody positive (Wellenberg et al., 
2004) and in Taiwan 83.5% of pigs were sero-positive (Chun et al., 2004). PCV2 
infection is present in almost 100% of Spanish pig herds (Lopez-Soria et al., 2005) and in 
Canada the presence of virus has been demonstrated in all pig herds examined (Harding, 
2004). In a retrospective study carried out in Northern Ireland, 78% of porcine sera 
collected between 1973 to 1999 were shown to be PCV2 antibody positive, with more 
animals positive in the latter years i.e. 100% in 1998 compared to 69.1% in 1973 (Walker 
et al., 2000).
Results of this study indicate that PCV2 is widespread in pig herds in Ireland, 
regardless of whether PMWS occurs in these herds. Active seroconversion generally 
occurs 3 to 4 weeks after weaning at 8 to 12 weeks of age (Clark, 1997). A very large 
variation was observed in antibody titres within herds; this was seen to vary from the 
lowest (<l/250) to the highest titre (1/156,250) detectable with this test. This may reflect 
variation in the immune responses of individual animals to PCV2 and/or it may reflect
3.5 Discussion
71
differences in the amount of time elapsed since the animals were exposed to the virus. 
Inadequate colostrum intake may allow primary infection in pigs when younger thereby 
advancing the disease, while maternal antibody would therefore delay infection.
An interesting observation in this study was that the four PCV2 sero-negative 
herds were all small hobby/backyard herds. A total of 10 hobby herds were tested for the 
presence of PCV2 antibodies. This indicates that PCV2 infection is predominantly a 
commercial herd problem in Ireland. However, from this study it can be concluded that 
PCV2 infection is widespread in the commercial pig population of Ireland. A large 
proportion of Irish herds are sero-positive and a high within-herd seroprevalence is found 
in positive herds and is present in both large commercial fattening units and some small 
backyard or “hobby” herds. It has also been reported elsewhere that individual pigs with 
PMWS can be found either in herds with high mortality and pig losses or in herds with 
very good productive levels and minimal mortality, in large fattening units or small 
backyard herds (Segales and Morvan, 2004). From this study it can be seen that PCV2 
infection is present in both commercial herds and hobby herds, however it is more 
prevalent in commercial herds.
Confirmed PMWS in Ireland was determined over a one year period from the 
suspect herd samples submitted. The proportion that were deemed to be PMWS-affected 
in the ROI and NI were 80% and 45.2% respectively. The percentages of suspect herds 
that were shown to be PMWS-affected in both the North and South of Ireland were large 
in comparison to other studies that have been reported. However this may be a reflection
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of the selectivity of submissions of suspect cases in the present study. There are a total of 
1149 active Irish pig herds in ROI and one possibility is that suspect PMWS herds were 
not submitted as frequently in the South of Ireland. Although laboratory confirmation of 
the disease is necessary it is possible that many specialist pig veterinarians may have 
clinically recognized PMWS in the herd and made a diagnosis without submitting suspect 
samples to the laboratory. In a study carried out by Kim et al., (2002) over a two year 
period (1999 and 2000), 8.1% of herds were PMWS positive in Korea (these samples 
were selected as they were submitted for diagnosis to the Department of Veterinary 
Pathology, Seoul University) (JungHyun et al., 2002). In a Danish study (October 2001 
to September 2003) 277 of the 6,624 herds (4.1%) from which specimens were submitted 
were PMWS positive; this represents 1.3% of the total number of pig herds registered in 
Denmark (Vigre et al., 2005).
The principal clinical and necropsy findings observed in positive herds in the 
North and South of Ireland included wasting, respiratory distress, lymph node 
enlargement, diarrhoea and pneumonia. Wasting was the most common finding in both 
NI and ROI. There were some reported findings in the ROI which included pallor, GIT 
ulceration, kidney lesions and sudden death which were not reported in Northern Ireland 
in PMWS affected herds. Clinical signs observed and post-mortem changes coincided 
with those described in the literature for PMWS (Harding et al., 1998; Allan and Ellis, 
2000a; Allan, 2002). Many of the findings reported were common to both affected and 
non-affected herds, but more frequent in the affected herds. Many of the clinical signs of 
PMWS can correspond to signs associated with other diseases such as acute classical
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swine fever (CSF) or PRRS. Therefore a differential diagnosis and laboratory 
confirmation of infection/disease is crucial when investigating field cases of PMWS 
(Jemersic et al., 2004).
The histopathological lesions observed on PMWS-affected herds in ROI and NI 
coincided with those already described in the literature for PMWS (Segales and 
Domingo, 2002). A strong correlation was observed between histopathological lesions 
and the level of PCV2 antigen present in the tissue (IFA and IHC) in PMWS positive 
herds. Some of the lesions were common to both PMWS positive and negative herds, 
namely bronchopneumonia and lymphocytic depletion. It is possible in cases where 
slight lymphoid lesions and low amounts of PCV2 were detected that the pigs were only 
at the initial stages of the disease or the animals may have been in a convalescent period 
after suffering from PMWS (Segales and Domingo, 2002).
As can be seen from Table 3.3 the results of IFA and IHC do not always agree on 
an animal-to-animal basis in PMWS-affected herds. However, on a herd unit basis these 
results do agree, i.e. is the herd affected by PMWS. Deviations may often occur in tissue 
sections, which may result in one part of the tissue having a higher level of the PCV2 
antigen than another. Therefore, the authors recommend that all tissue samples be tested 
in duplicate or as was the case in this study both IFA and IHC be performed together with 
histopathology. This supports the importance of the three criteria (Clark, 1997) when 
diagnosing a herd with PMWS, and if  all tests are performed then the risk of 
misdiagnosing an animal is reduced. Where conflicting results did arise a positive result
74
was given as long as there was sufficient antigen present on the tissue to indicate PMWS 
together with characteristic histopathological lesions. PCV2 is an important pathogen 
whose clinical expression in swine is associated with a number of different syndromes 
and diseases in pigs such as PDNS, reproductive failure, PRDC, granulomatous enteritis, 
necrotizing lymphadenitis and possibly exudative epidermitis (Chae, 2005). Until 
recently PMWS often remained overlooked and undiagnosed, many findings being 
attributed to stress or other disease phenomena. Retrospective studies have also 
demonstrated that PCV2 associated cases of PMWS have been present from at least 1985 
onwards and were not recognized as PMWS (Toplak et al., 2004). Such retrospective 
studies have shown that PMWS has occurred since at least 1986 in Spain, 1989 in Japan, 
and 1993 in Thailand (Staebler et al., 2005).
75
Chapter 4: Genome sequence analysis of PCV2 
isolates from PMWS-affected and non-affected
pigs in Ireland
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The entire genome of Irish isolates (ROI and NI) of PCV2 from both diseased and 
non-diseased animals were amplified by PCR and sequenced. To determine the extent of 
genetic diversity of Irish isolates from diseased and non-diseased animals and from 
isolates originating from other countries a phylogenetic analyses was performed on Irish 
PCV2 sequences and compared to sequences already published in GenBank. Sequence 
analysis of the complete genome indicated that the Irish PCV2 isolates analysed in the 
present study are closely related to each other but also to other PCV2 strains originating 
from Western Canada, USA, other parts of Europe and Asia. Phylogenetic analyses of 
all isolates revealed one large cluster composed of isolates from USA, Canada, Spain, 
Germany and Taiwan. A closely related second cluster was composed of ROI isolates 
from non-diseased animals and two ROI isolates from diseased animals. Isolates from 
France, Nethlerlands, UK and NI were found to be closely related to each other.
Sequence analysis of ORF1 and ORF2 genes of the 21 Irish isolates revealed that 
there were very few nucleotide changes between isolates from both parts of Ireland and 
PMWS-negative isolates within ORF2; most nucleotide changes occurred within the 
ORF1 gene.
4.1 A b strac t
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In order to determine the genetic heterogeneity among PCV2 isolates from 
diseased and non-diseased pigs in Ireland, the complete genome of PCV2 was amplified 
by PCR and sequenced. A phylogenetic analysis of these PCV2 genomes was then 
carried out in order to assess the possibility of the circulation of virulent and non-virulent 
strains of the virus resulting in the epizootic form of the disease or the presence of a 
novel genotype of PCV2. To more fully understand the genetic diversity of the virus a 
phylogentic analysis was also performed on strains from Ireland and other countries from 
sequences already published in GenBank including starains from Europe, Canada, 
America and Asia.
4.2 In tro d u c tio n
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Sample Sources'. Various tissue samples (lymph nodes, lung, liver) were collected from 
pigs, which were submitted to the CVRL (DAF) as suspect PMWS cases as described in 
chapter 3. These tissues were confirmed either positive or negative for PMWS by IF A 
and/or IHC, histopathology and PCR and stored at -70°C until use. The complete PCV2 
genome was amplified by PCR and sequenced from tissues from seven PMWS-affected 
and three non-affected animals from ROI. Isolates N4, N5 and N6 were from PMWS 
negative pigs and isolates 2, 3, 5, 6, 7, 10 and 12 were from confirmed field cases of 
PMWS (isolate reference number does not relate to farm number in chapter 3). From NI 
DNA was extracted from ten tissue samples (samples A -  J) from PMWS-positive field 
cases and a faecal sample from one negative case (V2) (as analysed by DARDNI) were 
amplified by PCR and sequenced.
Isolation of DNA from tissues: DNA was extracted from the various tissue samples with 
the Dneasy Tissue Kit (Qiagen Inc.) according to the manufacturers instructions. For 
each DNA extraction 25mg of tissue sample was used.
PCR amplification of the complete genome of PCV2: Four sets of primer pairs were used, 
as described in Chapter 2. These primer pairs amplified overlapping fragments that 
represent the entire genome of PCV2. The extracted DNA was amplified by PCR with 
HotStarTaq® PCR Kit (Qiagen Inc.). The PCR consisted of 35 cycles of denaturation at 
94°C for 1 minute, annealing at 55°C for 1 minute (primers CV3,4,5,6,7,8) or 51°C 
(primer pair CV1,2) and extension at 72°C for 3 minutes, followed by a terminal
4.3 M ateria ls  & M ethods
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extension at 72°C for 7 minutes. PCR products of expected size were purified by 
electrophoresis on a 2% agarose gel, followed by a clean up using the QIAquick PCR 
Purification Kit (Qiagen). Purified PCR products were sequenced in both directions by 
MWG BIOTECH, Germany.
Figure 4.1 : Genome of PCV2. Overlapping PCR fragments used to determine the
complete genome of PCV2 and origin of replication are indicated in the 
circular map.
Sequence Analysis'. The nucleotide sequences were aligned using the ClustalW version 
1.83 multiple sequence alignment programme http : //www. ebi. ac.uk/clustalw/. It 
produces biologically meaningful multiple sequence alignments of divergent sequences. 
It calculates the best match for the selected sequences, and lines them up so that the 
identities, similarities and differences can be seen. A phylogenetic analyses was first 
performed on aligned data from ROI and NI in order to determine if there was much
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difference in nucleotide sequence between isolates from pigs which were affected and 
those non-affected by PMWS on the island of Ireland. A phylogenetic analysis was 
performed on the aligned data set and an unrooted tree was constructed. Besides the 21 
PCV2 sequences reported in this study, 12 PCV2 genomic sequences published in 
GenBank database, listed in table 4.1 with their geographic origin, were also included in 
an additional phylogenetic analysis. Alignments of the complete viral genomes were 
performed.
4 .4  Results
4.4.1. Sequence Analysis
On the island of Ireland the complete genomic nucleotide sequences of 10 PCV2 
isolates from ROI and 11 PCV2 isolates from NI from diseased and non-diseased animals 
(table 4.1) were determined and found to be 1767 nucleotides (nt) in length. ROI and NI 
isolates were closely related to each other displaying 97-100% overall nucleotide 
homology (figure 4.2). When these PCV2 isolates were aligned along with other isolates 
chosen randomly from GenBank (table 4.2) PCV2 isolates showed 94-100% overall 
nucleotide homology (figure 4.3).
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Isolate ID PM WS 
Status
Isolate ID PMWS 
Status
2 Pos A Pos
3 Pos B Pos
5 Pos C Pos
6 Pos D Pos
7 Pos E Pos
10 Pos F Pos
12 Pos G Pos
N4 Neg H Pos
N5 Neg I Pos
N6 Neg J Pos
V2 Neg
Table 4.1: Identification of PCV2 isolates from suspect field cases of PMWS in
Ireland
4.4.2 Phylogenetic Analysis of PCV2 isolates
In the phylogenetic analysis of all genomic sequences, trees were constructed by 
the ClustalW programme and are presented in phylogram format. A phylogenetic tree 
resulting from the analysis of the total viral genomes of PCV2 isolates from both ROI 
and NI was created (figure 4.4). This tree displayed a large cluster divided into small 
groups containing sequences from the PMWS negative pigs from ROI in one small group 
close to pigs B and 12. Another small group off this main cluster contained isolates D 
and E with another group containing isolate A. All remaining pigs were aligned along
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the main branch of the tree. A small group existed on this main branch containing 
isolates F, G, I, J and V2.
Figure 4.4: Phylogenetic analyses of PCV2 complete genomes from aligned
sequences of 11 ROI sequences and 11 NI sequences. PMWS negative 
sequences are shown in boxes.
The final tree constructed (figure 4.5) consisted of genomic sequences from both 
parts of Ireland and other sequences found in GenBank (table 4.2) in order to compare 
Irish PCV2 sequences with others worldwide. This phylogram contained 3 clusters. One 
large cluster consisted of four small groups. The first group was divided into two sub­
groups, the first contained isolates from the US, Canada and Germany, the other sub­
group contained isolates from Spain and Taiwan. Isolate B from NI and 12 from ROI 
were both in groups on their own. The negative sequences from ROI were also in a sub­
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group together. Two small clusters could be observed off the main branch, the first was 
divided into two groups containing strains from France and the Netherlands and NI in the 
other sub-group. In the other small cluster off the main branch NI strains (V2, G, F, I and 
J) were situated in the other cluster. The remaining NI and ROI strains were positioned 
off the main branch of the tree.
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Figure 4.5: Phylogenetic analysis of PCV2 complete genomes. Tree was constructed
from aligned nucleic acid sequences of 10 ROI strains, 11 sequences from
NI strains and 12 sequences from GenBank. PMWS negative sequences
are shown in boxes.
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Isolate ID/ 
Original name
Geographic
origin
Genbank 
Accession no.
Reference
Im p.9 9 9 U S A F 0 5 5 3 9 1 M eehan e t  a l. ,  1998
Im p.lO lO -Stoon 
(archetype strain)
Canada A F 0 5 5 3 9 2 M eehan e t  a l . ,  1998
Im p lO l  1 -4 8 1 2 1  (F R A 1 ) France A F 0 5 5 3 9 3 M eehan e t  a l . ,  1998
I m p .1 0 1 1 -4 8 2 8 5  (F R A 2 ) France A F 0 5 5 3 9 4 M eehan e t  a l. ,  1998
G E R 1 Germany A F 2 0 1 3 0 5 Mankertz e t  a l.,  2 0 0 0
G E R 2 Germany A F 2 0 1 3 0 6 Mankertz e t  a l.,  2 0 0 0
SPA1 Spain A F 2 0 1 3 0 8 Mankertz e t  a l. ,  2 0 0 0
S P A 2 Spain A F 2 0 1 3 0 9 Mankertz e t  a l. ,  2 0 0 0
M L T W 9 8  (T A 1 ) Taiwan A F 1 5 4 6 7 9 K uo e t  a l. ,  unp*
T aiw an (T A 2 ) Taiwan A F 1 6 6 5 2 8 Y a n g  e t  a l. ,  unp*
2 4 6 5 7  N L Netherlands A F 2 0 1 8 9 7 W ellenberg e t  a l . ,unp*
Imp. 114 7 U K A J2 9 3 8 6 9 M eehan e t  a l . ,  2001
* unpublished
Table 4.2: Identification of PCV2 isolates previously reported and for which
sequence was obtained from GenBank
4.4.3 Analysis of ORF’s
The positions of the 6 open reading frames (ORF’s) of PCV2 are outlined in 
figure 4.8. Sequence comparisons of the ORF2 gene coding for the putative capsid 
protein of the PCV2 ROI and NI isolates revealed that the nucleotide sequence homology 
ranged between 95 -  100% (figure 4.2). ORF2 of PCV2 is 702 nt’s in length. Irish 
isolates were translated using Transeq fhttp://www.ebi.ac.uk/emboss/transeq/~). When
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translated 0RF2 genes were found to encode proteins of 233 aa residues with a deletion 
at the end of the sequence, except for isolates 2 and 7 from ROI which encoded a protein 
of 234 aa residues. When aligned these aa sequences showed an overall aa homology of 
93 - 100% (figure 4.6).
Sequence comparisons of the ORF1 gene coding for the Rep protein of the PCV2 
ROI and NI isolates revealed that the nucleotide sequence homology ranged between 97- 
100% (figure 4.2). ORF1 of PCV2 is 945 nt’s in length when translated ORF1 genes 
were found to encode proteins of 314 aa’s with a deletion at the end of the sequence. 
When aligned these aa sequences showed an overall aa homology of 98-100% (figure
4.7).
ORF2
329- 
360
Figure 4.8: Genome organisation of PCV2. The two major ORF’s are indicated by
hatched boxes, the nt positions of these major ORF’s are shown, black 
arrows show the positions and orientations of the smaller ORF’s.
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4.5 Discussion
Sequence analysis of the complete genome of PCV2 isolates from diseased and 
non-diseased pigs in Ireland indicated that they are very closely related to one another 
(lowest homology 96%) and to other PCV2 isolates originating from Europe, USA, 
Canada and Asia (lowest homology 94%).
Most phylogenetic analyses of PCV2 isolates reported to date have been 
performed on PCV2 isolates identified from PMWS cases (Larochelle et al., 2002). In 
this study we report the phylogenetic analyses of Irish PCV2 isolates identified from 
PMWS affected and non-affected pigs and these were then compared with 12 PCV2 
sequences from GenBank, representing isolates from PMWS cases from different 
countries. In the phylogenetic analyses when ROI isolates were compared to NI isolates 
one large cluster was revealed and showed that isolate B from a PMWS affected pig from 
NI was found closely related to the PCV2 isolates from non-PMWS pigs from ROI and 
PMWS-positive pig 12. Isolates A, D and E were also found in sub-clusters of this. All 
other isolates analysed were found along the main branch of the tree. One small group 
was revealed that contained strain V2 identified from a healthy pig in NI along with 
strains F, V, I and J from field cases of PMWS pigs from NI.
When these PCY2 isolates were analysed along with sequences already published 
in GenBank it could be seen that that they are closely related to each other showing a 
lowest homology of 94%. It was seen that isolates from the US, Canada, Germany, Spain 
and Taiwan were closely related to one another and positioned together in a sub-cluster.
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This sub-cluster was found positioned closely to the sub-cluster containing ROI 
sequences N4, N5, N6 and 12 and NI sequence B. Sequences from the Netherlands and 
France were found to be closely related to sequences D, E and A from NI. All remaining 
sequences from ROI, NI and the UK were spread in small groupings along the 
phylogenetic tree.
PCV2 contains 6 ORF’s larger than 200nt’s but proteins seem to be expressed 
only by ORF1 and ORF2. The ORF1 is 945 nt in length and encodes a protein of 35.7 
kDa involved in viral replication, the Rep protein. The DNA replicase is a protein of 314 
aa for PCV2 (Meehan et al., 1998). PCV2 DNA requires 2 proteins (Rep and Rep’) for 
replication (Cheung, 2004a). The PCV2 ORF2 is 702 nt in length and has been shown to 
encode the major capsid protein (Allan and Ellis 2000a) of approximately 30 kDa 
(Lekcharoensuk et al., 2004). The capsid protein contains a nuclear localization 
sequence which binds to cell nucleoli presumably facilitating encapsidation of viral 
DNA. The origin of PCV DNA replication (Ori) is contained within a conserved single 
stem loop configuration at nt positions 329-360 (figure 4.1) (Meehan et al., 1998). 
Recombinant PCV2 ORF2 protein self-assembles into icosahedral structures and at least 
three immunoreactive epitopes have been identified (Mahé et al., 2000). As can be seen 
from figure 4.2 there were no nt changes at the Ori in all isolates in this study.
Sequence analysis of Irish PCV2 ORF2 gene, which encodes for the major 
structural capsid protein indicated that the ORF2 gene encodes a protein of 233 and 234 
amino acid residues and revealed a lowest nucleotide homology of 95% and lowest
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amino acid homology of 93%. Most nt sequence changes appeared to occur in the ORF2 
between isolates when compared to other countries (figure 4.3), however there were very 
few nt changes between isolates from both parts of Ireland and PMWS-negative isolates 
were very similar to PMWS-positive isolates within ORF2 (figure 4.2). A deletion of a T 
nt was found on position 1389 (within ORF2), this nt was present in isolates from US, 
Canada, Germany, Spain and Taiwan but was absent in all other isolates from ROI, NI 
(diseased and non-diseased animals), France, The Netherlands and UK. Within the 
ORF2 no nt substitutions occoured in isolate V2 compared to diseased isolates from 
Ireland and there was only one nt change in N4, N5 and N6 at nt 1514 where a T was 
substituted for a C. An aa alignment showed that at aa 190 an A was substituted for a T 
in non-diseased animals in ROI and there was no change in the aa sequence for the non­
diseased animal in NI. Sequence analysis of more isolates from negative herds in NI is 
required in order to determine if this substitution is significant, more work in this area is 
currently being undertaken by DARDNI.
Sequence analysis of Irish PCV2 ORF1 gene, which encodes for the Rep protein 
indicated that the ORF1 gene encodes a protein of 314 amino acid residues and revealed 
a lowest nucleotide homology of 97% and lowest amino acid homology of 98%. Most nt 
changes in N4, N5 and N6 occurred within ORF1 at nt’s 514, 565, 601, 604, 619, 664, 
685, 711, 714 and 736. Only one nt substitution existed in isolate V2 this occoured at nt 
994. An aa alignment showed that at aa 34 of the ORF1 a D was substituted for an E in 
non-diseased animals (N4, N5 and N6) this substitution was also in PMWS-affected 
animal 12 from ROI. Other aa changes in non-diseased animals occurred at aa’s 74
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where a K was substituted for an N and aa 77 where an L was substituted for an F. There 
were no aa substitutions in V2 in ORF1.
As the ORF2-encoded protein is the major structural antigen of the virus, changes 
to its primary sequence may result in an altered immune response to PCV2, either due to 
an alteration of T cell immunoreatcive epitopes or the binding sites for neutralising 
antibodies. Other genomic changes, whilst not affecting immunogenicity per se, may 
affect the pathogenicity of a given PCV2 isolate by leading to changes in mRNA or 
protein stability, potentially leading to altered rates of viral replication. Investigating the 
impact of such changes would require a strategy involving the incorporation of specific 
sequence changes into recombinant PCV2 followed by experimental infection of pigs.
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Figure 4.2: Nucleotide sequences alignm ent o f  the complete genome o f  P C V 2  from
R O I and N I  isolates from  diseased and non-diseased animals. The  
positions o f  the two m ajor O R F ’s, ORF1 and O R F2 and the Origin o f  
Replication are indicated. Changes in the nucleotide sequence are 
highlighted.
ORF2
6 AATTCAACCTTAACCTTTCTTATTCTGTAGTATTCAAAGGGCACAGAGCGGGGGTTTGAG 60
7 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Q * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
J Q *********************************************************************************
^ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
p  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
G * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
j  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
j  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Y2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
j_j * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
D  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
g *************************Q******************** ********************* *************
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
22 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
g  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
ORF2
6 CCCCCTCCTGGGGGAAGAAAGTCATTAATATTGAATCTCATCATGTCCACCGCCCAGGAG 120
y * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Q  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
|Q * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
P * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
0  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
J * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
J * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Y2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
j-j * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Q * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
g  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
12 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
3  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
ORF2
6 GGCGTTTTGACTGTGGTTCGCTTGATAGTATATCCGA AGGTGCGGGAG AGGCGGGTGTTG 180
y  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Q  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IQ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
p * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
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Figure 4.3: Nucleotide sequence alignm ent o f  the complete genome o f  Irish isolates o f
P C V 2  w ith  isolates from other countries already present in GenBank, 
changes in nt sequence are highlighted in red. Deletions are shown by 
dashes. O n ly  2 isolates from  diseased animals in R O I and 4 from N I  are 
represented as no changes existed in other sequences
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Gerl AATTCAACCTTAACCTTTCTTATTCTGTAGTATTCAAAGGGT AT AGAGATTTTGTTGGTC
Ger2 AATTCAACCTTAACCTTTCTTATTCTGTAGTATTCAAAGGGT AT AGAGATTTTGTTGGTC
Spal AATTCTACCTTAACCTTTCTTATTCTGTAGTATTCAAAGGGTATAGAGATTTTGTTGGTC
Spa2 AATTCAACCTTAACCTTTCTTATTCTGTAGTATTCAAAGGGT AT AGAGATTTT GTTGGTC
Tal AATTC AACCTTAACCTTTCTTATTCTGT AGT ATTCAA AGGGT AT AGAGATTTT GTTGGTC
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G er2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
§pal * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Spa2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
j a2  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
V2 AAGCGGACCCCAACCCCATAAAAGGTGGGTGTTCACTCTGAATAATCCTTCCGAAGACGA 480
C * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
ß * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Pp.g 2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
jsjp * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
pra2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
pj * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
g  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
12 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
N5 AAGCGGACCCCAACCACACAAAAGGTGGGTGTTCACGCTGAATAATCCTTCCGAAGACGA
N6 AAGCGGACCCCAACCACACAAAAGGTGGGTGTTCACGCTGAATAATCCTTCCGAAGACGA
N4 AAGCGGACCCCAACCACACAAAAGGTGGGTGTTCACGCTGAATAATCCTTCCGAAGACGA
Q * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
US AAGCGGACCCCAACCACATAAAAGGTGGGTGTTCACGCTGAATAATCCTTCCGAAGACGA
Can 1010 AAGCGGACCCC AACCAC ATAAAAGGTGGGTGTTCACG CTGAATAATCCTTCCGAAGACGA
Gerl AAGCGGACCCCAACCACATAAAAGGTGGGTGTTCACGCTGAATAATCCTTCCGAAGACGA
Ger2 AAGCGGACCCCAACCACATAAAAGGTGGGTGTTCACGCTGAATAATCCTTCCGAAGACGA
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Figure 4.3 Continued
Spal AAGCGGACCCCAACCACACAAAAGGTGGGTGTTCACGCTGAATAATCCTTCCGAAGACGA
Spa2 AAGCGGACCCCAACCACACAAAAGGTGGGTGTTCACGCTGAATAATCCTTCCGAAGACGA
Tal AAGCGGACCCCAACCACATAAAAGGTGGGTGTTCACGCTCAATAATCCTTCCGAAGACGA
Ta2 AAGCGGACCCCAACCACATAAAAGGTGGGTGTTCACGCTCAATAATCCTTCCGAAGACGA
V2 GCGCAAGAAAATACGGGATCTTCCAATATCCCTATTTGATTATTTTATTGTTGGCGAGGA 540
Q a M c****** *** ** * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
£ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
praJ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Pl*a2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
J) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Jg * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
12 GCGCAAGAAAATACGGGAGCTTCCAATCTCCCTGTTTGATTATTTTATTGTTGGCGAGGA
N5 GCGCAAGAAAATACGGGAGCTTCCAATCTCCCTTTTTGATTATTTTATTGTTGGCGAGGA
N6 GCGCAAGAAAATACGGGAGCTTCCAATCTCCCTTTTTGATTATTTTATTGTTGGCGAGGA
N4 GCGCAAGAAAATACGGGAGCTTCCAATCTCCCTTTTTGATTATTTTATTGTTGGCGAGGA
B GCGCAAGAAAATACGGGATCTTCCAATATCCCTATTTGATTATTTTATTGTTGGCGAGGA
US GCGCAAGAAAATACGGGAGCTCCCAATCTCCCTATTTGATTATTTTATTGTTGGCGAGGA
CanlOlO GCGCAAGAAAATACGGGAGCTCCCAATCTCCCTATTTGATTATTTTATTGTTGGCGAGGA
Gerl GCGCAAGAAAATACGGGAGCTTCCAATCTCCCTGTTTGATTATTTTATTGTTGGCGAGGA
Ger2 GCGCAAGAAAATACGGGAGCTTCCAATCTCCCTGTTTGATTATTTTATTGTTGGCGAGGA
Spal GCGCAAGAAAATACGGGAGCTTCCAATCTCCCTGTTTGATTATTTTATTGTTGGCGAGGA
Spa2 GCGCAAGAAAATACGGGAGCTTCCAATCTCCCTrTTTGATTATTTTATTGTTGGCGAGGA
Ta 1 GCGCAAGAAAATACGGG AGCTCCCAATCTCCCTATTTGATTGTTTTATTGTTGGCGAGGA
j a2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
V2 GGGTAATGAGGAAGGACGAACACCTCACCTCCAGGGGTTCGCTAATTTTGTGAAGAAGCA 600
q * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
 ^ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
A GGGTAATGAGGAAGGACGAACACCTCACCTTCAGGGGTTCGCTAATTTTGTGAAGAAGCA
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
PYa9 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
D GGGTAATGAGGAAGGACGAACACCTCACCTTCAGGGGTTCGCTAATTTTGTGAAGAAGCA
£  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
12 GGGTAATGAGGAAGGACGAACACCTCACCTTCAGGGGTTCGCTAATTTTGTGAAAAAGCA
N5 GGGTAATGAGGAAGGACGAACACCCCACCTCCAGGGGTTCGCTAATTTTGTGAAGAAGCA
N6 GGGTAATGAGGAAGGACGAACACCCCACCTCCAGGGGTTCGCTAATTTTGTGAAGAAGCA
N4 GGGTAATGAGGAAGGACGAACACCCCACCTCCAGGGGTTCGCTAATTTTGTGAAGAAGCA
g ************** ************************************ *******************************
jjg * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Can 1010 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Gerl GGGTAATGAGGAAGGACGAACACCTCACCTCCAGGGGTTCGCTAATTTTGTGAAAAAGCA
Ger2 GGGTAATGAGGAAGGACGAACACCTCACCTCCAGGGGTTCGCTAATTTTGTGAAAAAGCA
Spal GGGTAATGAGGAAGGACGAACACCCCACCTCCAGGGGTTCGCTAATTTTGTGAAGAAGCA
Spa2 GGGTAATGAGGAAGGACGAACACCCCACCTCCAGGGGTTCGCTAATTTTGTGAAGAAGCA
Tal GGGTAATGAGGAAGGCCGAACACCCCACCTACAGGGGTTCGCTAATTTTGTGAAGAAGCA
Ta2 GGGTAATGAGGAAGGCCGAACACCCCACCTACAGGGGTTCGCTAATTTTGTGAAGAAGCA
V2 GACTTTTAATAAAGTGAAGTGGTATTTGGGTGCCCGCTGCCACATCGAGAAAGCGAAAGG660
0 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
g * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
pral * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Ppq2 *********************************************************************************
Q * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
g * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
12 A ACTTTTAATAAAGTGAAGTGGTATCTTGGTGCCCGCTGCCAC ATCGAGAAAGCC AAAGG
N5 AACATTTAATAAAGTGAAATGGTATTTCGGTGCCCGCTGCCACATCGAGAAAGCGAAAGG
N6 AACATTTAATAAAGTGAAATGGTATTTCGGTGCCCGCTGCCACATCGAGAAAGCGAAAGG
N4 AACATTTAATAAAGTGAATTGGTATTTCGGTGCCCGCTGCCACATCGAGAAAGCGAAAGG
105
B GACTTTTAATAAAGTGAAGTGGTATTTGGGTGCTCGCTGCCACATCGAGAAAGCGAAAGG
US AACTTTTAATAAAGTGAAGTGGTATTTGGGTGCCCGCTGCCACATCGAGAAAGCCAAAGG
Can 1010 AACTTTTAAT AAAGTGA AGTGGTATTTGGGTGCCCGCTGCCAC ATCGAG AAAGCC AA AGG
Gerì AACATTTAATAAAGTGAAGTGGTATCTTGGTGCCCGCTGCCACATCGAGAAAGCCAAAGG
Ger2 GACATTTAATAAAGTGAAGTGGTATCTTGGTGCCCGCTGCCACATCGAGAAAGCCAAAGG
Spa 1 A AC ATTTAATAAAGTGAA ATGGTATTTGGGTGCCCGCTGCCAC ATCGAGAAAGCGAAAGG
Spa2 AAC ATTTAATAAAGTGAA ATGGTATTTGGGTGCCCGCTGCCAC ATCGAGAAAGCGAAAGG
Tal AACTTTTAATAAAGTGAAGTGGTATTTTGGTGCCCGCTGCCACATCGAGAAAGCGAAAGG
Ta2 AACTTTTAATAAAGTGAAGTGGTATTTTGGTGCCCGCTGCCACATCGAGAAAGCGAAAGG
V2 AACAGATCAGCAGAATAAAGAATACTGCAGTAAAGAAGGCAACTTACTGATCGAGTGTGG 720
G * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
fi * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Uj£ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Frai AACAGATCAGCAGAATAAAGAATACTGCAGTAAAGAAGGCAACTTACTGATGGAGTGTGG
NL AACAGATCAGCAGAAIAAAGAATACTGCAGTAAAGAAGGCAACTTACTGATGGAGTGTGG
Fra2 AACAGATCAGCAGAATAAAGAATACTGCAGTAAAGAAGGCAACTTACTGATGGAGTGTGG
D AACAGATCAGCAGAATAAAGAATACTGCAGTAAAGAAGGCAACTTACTGATGGAGTGTGG
E AACAGATCAGCAGAATAAAGAATACTGCAGTAAAGAAGGCAACTTACTGATGGAGTGTGG
12 A ACTGATCAGCAGAATAAAGAATATTGCAGTAAAGAAGGCAACTTACTTATTGAGTGTGG
N5 AACTGATCAGCAGAATAAAGAATATTGCAGTAAAGAAGGCAACTTACTGATAGAATGTGG
N6 AACTGATCAGCAGAATAAAGAATATTGCAGTAAAGAAGGCAACTTACTGATAGAATGTGG
N4 AACTGATCAGCAGAATAAAGAATATTGCAGTAAAGAAGGCAACTTACTGATAGAATGTGG
B AACTGATCAGCAGAATAAAGAATATTGCAGTAAAGAAGGCAACTTACTGATGGAATGTGG
US AACTGATCAGCAGAATAAAGAATATTGCAGTAAAGAAGGCAACTTACTTATTGAATGTGG
Can 1010 AACTGATCAGCAG AATAAAGAATATTGCAGTAAAGAAGGC A ACTTACTTATTGAATGTGG
Gerì AACAGATCAGCAGAATAAAGAATATTGCAGTAAAGAAGGCAACTTACTTATTGAGTGTGG
Ger2 AACTGATCAGCAGAATAAAGAATATTGCAGTAAAGAAGGCAACTTACTTATTGAGTGTGG
Spai AACTGATCAGCAGAATAAAGAATATTGCAGTAAAGAAGGCAACTTACTGATTGAATGTGG
Spa2 AACTGATCAGCAGAATAAAGAATATTGCAGTAAAGAAGGCAACTTACTGATTGAATGTGG
Tal AACAGATCAGCAGAATAAAGAATACTGCAGTAAAGAAGGCAACTTACTTATCGAGTGTGG
Ta2 AACAGATCAGCAGAATAAAGAATACTGCAGTAAAGAAGGCAACTTACTTATCGAGTGTGG
V2 AGCTCCTAGATCTCAGGGACAACGGAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA 780
G * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
g * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
pj-g| * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
p * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
£) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
g * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
12 AGCTCCT AGATCTCAA GGACAACGGAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA
N5 AGCTCCTAGATCTCAAGGACAACGGAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA
N6 AGCTCCTCGATCTCAAGGACAACGGAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA
N4 AGCTCCTAGATCTCAAGGACAACGGAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA
g *********************************************************************************
US AGCTCCTCGATCTCAAGGACAACGGAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA
Can 1010 AGCTCCTCGATCTC AAGGAC A ACGGAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA
Gerì AGCTCCTAGATCTCAAGGACAACGGAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA
Ger2 AGCTCCTAGATCTCAAGGACAACGGAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA
gpa j * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Spa2 AGCTCCTAGATCTCAAGGACAACGGAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA
Tal AGCTCCTAGATCTCAAGGACAACGCAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA
Ta2 AGCTCCTAGATCTCAA GGACAACGCAGTGACCTGTCTACTGCTGTGAGTACCTTGTTGGA
V2 GAGCGGGAGTCTGGTGACCGTTGCAGAGCAGCACCCTGTAACGTTTGTCAGAAATTTCCG 840
Q *********************************************************************************
g * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Pj-gJ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
JyJL * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
pra2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
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US ACGGATATTGTAGTCCTGGTCGTATATACTGTTTTCGAACGCAGTGCCGAGGCCTACGTG 1500
Can 1010 ACGGAT ATTGT AGTCCTGGTCGTATTT ACTGTTTTCGAACGCAGCGCCGAGGCCT ACGTG
Gerl ACGGATATTGTAGTCCTGGTCGTATTTACTGTTTTCGAACGCAGTGCCGAGGCCTACGTG
Ger2 ACGGATATTGTAGTCCTGGTCGTATTTACTGTTTTCGAACGCAGTGCCGAGGCCTACGTG
Spai ACGGATATTGTAGTCCTGGTCGTATTTACTGTTTTCGAAGGCAGTGCCGAGGCCTACGTG
Spa2 ACGGATATTGTAGTCCTGGTCGTATTTACTGTTTTCGAAGGCAGTGCCGAGGCCTACGTG
Tal ACGGATATTGTAGTCCTGGTTGTATTTACTGTTTTCGAACGCAGTGCCGAGGCCTACGTG
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US GAAGGGTTGGGGGATTGTATGGCGGGAGGAGTAGTTTACATATGGGTCATAGGTTAGGGC 1680
Can 1010 GA AGGGTTGGGGGATTGTATGGCGGGAGGAGT AGTTTAC ATATGGGTC ATAGGTTAGGGC
Gerì GAAGGGTTGGGGGATTGTATGGCGGGAGGAGTAGTTTACATAGGGGTCATAGGTTTGGGC
Ger2 GAAGGGTTGGGGGATTGTATGCCGGGAGGAGTAGTTTACATAGGGGTCATAGGTTTGGGC
Spai GAAGGGTTGGGGTATGGTATGGCGGGAGGAGTAGTTTACATAGGGGTCATAGGTTAGGGC
Spa2 GAAGGGTTGGGG GATTGTATGGCGGGAGGAGT AGTTT AC AT AGGGGTCAT AGGTTAGGGC
Tal GAAGGGTTGGGGGATTGTATGGCGGGAGGAGTAGTTTACATAGGGGTCATAGGTTAGGGC
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Can 1010 TGTGGCCTTTGTTACAAAGTTATCATCTAGAATAACAGC AGTGGAGCCC ACTCCCCTATC
Gerì TGTGGCCTTTATTACAAAGTTGTCATCTAGAATAATAGCACTGGATCCAACTCCCCTGTC
Ger2 TGTGGCCTTTATTACAAAGTTGTCATCTAGAATAATAGCACTGGATCCAACTCCCCTGTC
Spai TGTGGACTTTGGAAAAAAGTTATCATCTAGAATAACAGCAGTGGAGCCCACTCCCCTATC
Spa2 TGTGGCCTTTGTTACAAAGTTATCATCTAGAATAACAGCAGTGGAGCCCACTCCCCTATC
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Ta2 TGTGGCCTTAGTTACAAAGTTATCATCTAGAATAACAGCAGTGGAGCCCACTCCCCTGTC
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Figure 4.6: A m ino A cid  A lignm ent o f  O R F 2 o f  P C V 2  o f  R O I and N I  isolates. A A
changes are highlighted in red.
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p * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Q * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
\ j2  ********************************************************************************
g  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
g  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
P) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
10 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^4 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
12 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
2 GGTVPFLARSILITSNQTPLEWYSSTAVPAVEALYRRITSLVFWKNATEQSTEEGGQFVT 300
3 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
g * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
~J ***************************************************************************
J * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
J * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
pi * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Q * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
p * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
C * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
^  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Y 2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
B GGTVPFLARSILITSNQTPLEWYSSAAVPAVEALYRRITSLVFWKNATEQSTEEGGQFVT 300
£  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
£) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
1Q * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
]sj4 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
12 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
2 LSPPCPEFPYEINY 314
3 * * * * * * * * * * * * * * *
5 * * * * * * * * * * * * * * *
5 * * * * * * * * * * * * * * *
7 * * * * * * * * * * * * * * *
j * * * * * * * * * * * * * * *
j  * * * * * * * * * * * * * * *
***************
Q ***************
p * * * * * * * * * * * * * * *
£  * * * * * * * * * * * * * * *
^ * * * * * * * * * * * * * * *
Y2 * * * * * * * * * * * * * * *
g * * * * * * * * * * * * * * *
g * * * * * * * * * * * * * * *
p) * * * * * * * * * * * * * * *
10 * * * * * * * * * * * * * * *
N5 * * * * * * * * * * * * * * *
N6/N4/12 * * * * * * * * * * * * * * *
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C h a p t e r  5 :  L o n g i t u d i n a l  C o h o r t  S t u d y  o f  
P M W S - a f f e c t e d  a n d  n o n - a f f e c t e d  H e r d s  i n
I r e l a n d
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5.1 Abstract
A  longitudinal study was performed on four herds from  Ireland. Three o f  these 
herds were from  R O I, tw o P M W S  positive herds and one negative control herd. The  
fourth herd was a P M W S  positive herd from  N I.  This study was undertaken in  order to 
elucidate any infectious/non-infectious “triggers” that m ay potentiate the enhanced P C V 2  
replication in infected pigs, w hich is associated w ith  P M W S . Five litters (approxim ately  
ten pigs per litter) from  each o f  the four herds were tagged on the first week o f  life , raised 
“norm ally” and were fo llow ed for ten consecutive weeks. Serum samples for P C V 2  
antibody titre and the presence o f  P P V  antibody, tonsil and faecal swabs fo r virus 
isolation and faecal swabs in  A im es charcoal fo r bacteriological isolation w ere taken at 
each visit.
A l l  pigs were positive fo r antibodies to P C V 2  on the first week o f  sampling and 
most pigs were seen to respond serologically b y  the final herd visit. In  P M W S  positive 
herds disease appeared to occur in  animals once maternal titres had declined. A ll  herds 
were P P V  antibody positive. In  all herds isolation o f  haemolytic E . c o l i  and 
C a m p y lo b a c te r  spp. appeared to be ubiquitous throughout the ten weeks, w hile isolation  
o f  S a lm o n e lla e  spp. was m ore sporadic w ith  none isolated from  the non-diseased herd 
and from  the N I  herd. The m ain viruses isolated from  these herds were Enterovirus 1 and 
2, reovirus and adenovirus.
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5.2 Introduction
It  has been established from  experimental infections that P C V 2  is the causative 
agent o f  P M W S  (A llan  e t a l,  1999a; A llan  e t a l ., 2003; K rakow ka e t a l. , 2000; Krakow ka  
e t a l. ,  2001)). H ow ever the pathogenesis o f  the disease is not fu lly  understood and the 
evidence suggests that additional co-factors are necessary (D arw ich  e t a l. , 2004). This  
longitudinal study was undertaken in order to elucidate the infectious/non-infectious 
“triggers” that m ay potentiate the enhanced P C V 2  replication in  infected pigs, which is 
associated w ith  P M W S .
N utritional deficiencies and excesses m ay both give rise to clinical diseases in  
pigs, affecting productivity in  both breeding and growing animals. Current porcine 
nutritional standards are based on research in  pigs o f  very different genotypes to those 
com m only found in herds nowadays. There are some concerns that dietary requirements 
at critical stages could contribute to the severity o f  P M W S , however, there is not enough 
scientific inform ation available to establish the real effect o f  nutrition in  this disease 
(A lla n  e t a l. ,  2005). I t  has also been suggested that the w ater supply could act as a 
potential pathw ay for the spread o f  P C V 2  or other potential disease causing organisms. 
The quality  o f  the w ater supplied and access to water has also the potential to affect 
grow th rates (M arco , 2005). I t  is also known that maternal im m unity and colostrum  
intake m ay have a significant bearing on progeny survival and that cross-fostering m ay  
p lay  a part in  P M W S  (A llan , 2005; M arco, 2005). Reducing stress on the suckler and 
n ew ly  weaned p ig  m ay help control the amount o f  P M W S  in  a herd and consequent 
m ortality. There m ay therefore be a relationship between the num ber o f  potential stress
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factors, whether they occur sequentially or concurrently, and subsequent m ortality  due to 
P M W S  (M adec, 2001; M arco, 2005). A lthough most breeder/feeders practice a ll-in /a ll- 
out management in the farrowing and weaner stages, m any practice continuous 
throughput in  their finishing houses and this compromises herd health. Some pig farmers 
are now  successfully practicing a ll-in /a ll-out management in  their finishing houses after 
changing to batch farrow ing and they report improved herd health (M arco, 2005). The  
risk that P M W S  could be spread by natural mating or through A I  cannot be ruled out. 
Traces o f  P C V 2  have been found in  boar semen but it is not known i f  the virus can 
survive there (H am el e t a l. , 2000). In  France it was found that herds w hich solely used 
A I  (no natural service) were at less risk o f  developing P M W S . How ever, others have 
suggested that P M W S  was associated w ith  a change in  the sourcing o f  semen (O hlinger 
and Pesch, 2000). A lthough the cofactors associated w ith  P M W S  rem ain a mystery, 
other diseases unquestionably exacerbate the clinical picture. M ost com m only implicated  
are P R R S  and PPV-associated illness.
A  longitudinal study was therefore undertaken on four Irish  herds to determine i f  
P C V 2  antibody titre, or other co-factors such as P P V , other viruses or bacterial organisms 
were involved in  exacerbating the disease in  Ireland.
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5.3 Materials & Methods
Four herds, three from  R O I and one N I  herd were chosen to take part in  this 
study. In  R O I tw o herds had been confirmed positive for P M W S  by the laboratory 
(C V R L ) and one was a negative control herd. In  N I  a confirmed PM W S -positive  herd 
was studied. A  fu ll history o f  each herd was taken on the first date o f  sampling and five  
litters (approxim ately ten pigs per litter) from  each o f  the four herds were tagged during 
the first w eek o f  life , raised “norm ally” and were fo llow ed for ten consecutive weeks.
H e rd  A : H erd “A ” was an indoor (on slats) integrated herd located in  County Cavan  
w hich finished over 20 ,000  pigs per year. A  P M W S  outbreak occurred in  this herd in  
Febuary 2004. The syndrome was in itia lly  suspected by  staff and confirmed by  clinical 
and laboratory examination. The clinical signs included laboured breathing, loss o f  
condition, wasting, nervous signs (loss o f  balance, paralysis) pneumonia, diarrhoea and 
sudden death. P re -P M W S , post weaning m ortality  on average was 3 .5% . A t the tim e o f  
the outbreak the m ortality  rate observed post-weaning to 30kg was 7%  w ith  a high o f  8% . 
The m ortality  rate in  pigs over 30kg was 2% . These high m ortality  rates continued for 2- 
3 months. A ll  animals were fed purchased compound. D ry  food pellets were fed to 
weaners and rearers and w et food to dry and lactating sows, growers and finishers. The 
w ater source was an on-farm  bore hole and disinfectants were not used when flushing out 
the w ater system. Pigs were cross-fostered after 48 hours and farrowings were managed 
by hormones. Batch farrow ing was carried out weekly. Around the tim e o f farrowing, 
pigs were closed away from  sows in  a creep area until dry. N o  changes were made w ith  
regard to cross-fostering and farrow ing methods as a result o f  P M W S . Piglets were
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in itia lly  injected w ith  iron w ith in  24  hours o f  birth. However, after the P M W S  outbreak 
this was no longer practiced. T a il docking and teeth clipping were still perform ed on the 
first day o f  life . Piglets were weaned at 29 to 30 days o f  age and were removed from  
suckling pens im m ediately afterwards and placed in  flat decks and fu lly  slatted pens. 
O rig inally , rearers were grouped according to size w ith in  one w eek o f  weaning, but 
fo llow ing the outbreak they were kept as groups o f  2 to 3 litters, w ith  21 to 30 weaners in  
each group, until 15 to 21 days after weaning. A n  all-in -a ll-ou t management system by  
room was in  operation. How ever, dry sows were not removed under this system. A ll  
sows were mated using purchased semen and the suppliers had not being changed in  the 
past 8 years. The breed m ake-up o f  the weaner/slaughter group was Landrace and Large 
W hite . A l l  pigs were vaccinated at weaning against enzootic pneumonia, erysipelas and 
E . c o l i  disease.
H e rd  B : H erd  ‘B ’ was an indoor (on slats) integrated herd located in  County C ork which  
finished over 20 ,000  pigs per year. P M W S  was diagnosed clin ically  in M a y  2004 and 
confirm ed by  laboratory examination. C lin ical signs included fever, jo in t problems, 
laboured breathing, loss o f  condition and wasting. Prior to the P M W S  outbreak, weaner 
m ortality  was 2% . This increased to 3 .5%  and then decreased again to 2 .5% . The 
m ortality  remained at the highest level for 10 to 12 months. A ll  pigs were fed a home 
m ix  and by-products w h ile  rations were analysed annually both before and after the 
outbreak. The home m illing  and m ixing used purchased wheat, barley and soya and the 
content o f  this food was not changed as a result o f  P M W S . The source o f  water for pigs 
was an on-farm  bore hole and V irko n  S™ (A ntec® , DuPont A n im al Health  Solutions,
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U nited  K ingdom ) was used fo r disinfecting. The water source was not altered as a result 
o f  the outbreak. It  was noticed on the farm b y  s ta ff that infected pigs had a preference for 
dirty  water o f f  the solid floor. Piglets were cross-fostered after 4  to 6 hours ingestion o f  
their m other’s colostrum. Farrowing was managed by the use o f  hormones and it was 
ensured that each p ig  had suckled w ell before fostering. A t the time o f  farrowing pigs 
were closed aw ay from  the sow in the creep area until dry and batch farrow ing was not in  
operation. N o  change in  management at farrow ing occurred as a result o f  P M W S . 
Piglets were injected w ith  iron, had their tails docked and their teeth clipped between 3 to 
5 days o f  age and w ere weaned at 27 to 28 days. F ifty-one to 75 pigs were placed in each 
rearer group. A n  a ll-in -a ll-ou t management system was operated by room, w ith  over 300  
pigs sharing the same common air space. This system remained in  operation fo llow ing  
the outbreak. Sows were mated by  natural service (up to 10% ) and b y  purchased semen 
(90  to 100% ). The source o f  A I  semen remained the same after the outbreak. Purchased 
replacement gilts w ere introduced on average every 6 to 9 months. Pigs were vaccinated 
against parvovirus reproductive disease (2 doses plus a booster), enzootic pneumonia and 
enterotoxaemia (C lo s t r id iu m  p e r f r in g e n s )  when aged 22 to 28 days.
H e rd  C : Herd ‘ C ’ , the negative control herd in  this study, was an integrated indoor
herd also located in  County Cork, w hich finished 5 ,000 to 10,000 pigs per year. Pigs 
were fed a homemade m ix, w ith  rations being analysed for m ineral content (calcium, 
phosphorous, salt and zinc) and vitam in content (vitamins A , B 12, D 3  and E ) every 6 
months. Cross-fostering occured after 4  to 6 hours ingestion o f  their m other’s colostrum  
and farrowings were managed b y  the use o f  hormones. Pigs remained w ith  the sows
123
when farrowing. Iron was injected between 3 to 5 days o f  age and tails were docked and 
teeth clipped w ith in  24 hours o f  birth. Piglets were weaned at 27 to 28 days o f  age and 
were im m ediately  removed from  their suckling pen and placed in  kennels. Litters were 
m ixed w ith in  one week o f  weaning, w ith  11 to 20 weaners in  each rearer group. Natural 
service (10  to 2 0% ) and A I  (80  to 90% ) were used for mating w ith  replacement boars 
being introduced every 12 to 18 months on average. Pigs were vaccinated against 
parvovirus reproductive disease and enzootic pneumonia.
H e rd  D : This herd is located in  N I  and had an on-going P M W S  problem.
Inform ation regarding the history o f  this herd was unavailable to the author as all w ork  
on this herd was carried out by  V S D  staff, Stormont and they did not complete the survey 
provided.
Samples from  each o f  the four herds were taken approxim ately every ten days for 
ten weeks (a total o f  7 visits). A t each visit, the fo llow ing samples were taken; serum  
samples [or P C V 2  antibody titre  ( IP M A ) and presence o f  P P V  antibody (E L IS A )] tonsil 
and feacal swabs in  V T M  fo r virus isolation and faecal swabs in  A im es charcoal 
buffer/transport m edium  fo r bacteriological isolation. Serum samples and swabs in V T M  
were stored at -20°C  and -70°C  respectively and a retrospective analysis was perform ed  
on a cohort o f  approxim ately 20  animals chosen from  herds A , B and C; a ll samples from  
herd D  were tested. The cohorts included diseased and non-diseased pigs chosen at 
random from  each litter. A l l  bacteriological samples were tested im m ediately upon 
arrival at the laboratory. The methods used are as outlined in chapter 2; section 2.5.
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5.4 Results
5.4.1 S e ru m  A n a ly s is
5 .4.1 .1  P C V 2  A n t ib o d y  T it re
The reciprocal antibody titre was determined on serum samples from  a cohort o f  
animals from  each o f  the three herds in  R O I using the IP M A  w ith  5 fo ld  dilutions (herd 
A , B  and C ). A l l  samples from  herd D  were tested using 2 fo ld dilutions as described in  
chapter 2.
H e rd  A :  S ix pigs (pigs no. 23, 28, 34, 32 56, 51) died during the study. Pigs 23,
28, 32 and 34 died after the first herd visit, post mortem revealed bleeding the pigs at 
such a young age as the cause o f  death. O n ly  one (pig no. 56) o f  these pigs was 
confirm ed positive for P M W S  b y  IF  A  and IH C , as described in  chapter 2. IF  A  on 
cryostat sections demonstrated high levels o f  P C V 2  antigen. A ll  other pigs that died had 
insufficient P C V 2  antigen on cryostat sections to indicate P M W S . A l l  pigs had maternal 
antibodies to P C V 2  in  the first w eek o f  life . M ost pigs were seen to respond 
serologically showing a four fo ld increase in  titre on the fourth or fifth  sampling date, 
approxim ately 40  to 50 days o f  age (figure 5 .1). The in itia l antibody titre in  the first 
w eek o f  life  varied between pigs, ranging from  250 to 31,250 reciprocal antibody titre 
w hile  the final antibody titre recorded for each p ig was usually 156,250 or 31 ,250 except 
in  tw o cases, p ig 19, w hich had a final titre o f  1,250 and pig 15 w hich  had a fina l tire o f  
6,250. P ig  56 had a reciprocal antibody titre o f  1,250 in  the first w eek o f  life  and on the 
5th sampling date this had reduced to 50 and on the 6th sampling date, at the time o f  death 
the reciprocal antibody titre was 0 (does not appear on a log scale graph).
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Figure 5.1: P C V 2  antibody titre o f  cohort o f  samples from  herd A  over the
observation period o f  ten weeks
H e rd  B: S ix pigs died during the study in H erd ‘B ’ (pigs no. 25, 36, 37, 40, 42, 49).
How ever, only tw o (pig no. 36, 4 2 ) o f  these were confirmed positive for P M W S  by IF A  
and IH C . IF A  on cryostat sections demonstrated high levels o f  P C V 2  antigen. A ll  other 
pigs that died had insufficient P C V 2  antigen on cryostat sections to indicate P M W S . 
Pigs were only bled from the second v is it to the herd. A ll pigs had maternal antibodies to 
P C V 2  (figure 5 .2). In  this herd most pigs were seen to respond serologically, w ith  a four­
fold increase in titre on the 6th farm  visit, at around 60 days o f  age. Both P M W S -affected  
pigs did not appear to mount an active im m une response to P C V 2 . P ig 36 died on the 4th 
herd visit and had a reciprocal antibody titre  o f  250  w hile pig 42 died on the final herd 
visit and had a reciprocal antibody titre o f  50.
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Figure 5.2: P C V 2  antibody titre o f  cohort o f  samples from  herd B over the
observation period o f  ten weeks
H e rd  C : One pig died (p ig no. 5) during this study. Flowever, it was confirmed as
P M W S  negative by IF A  and IH C  as there was insufficient P C V 2  antigen on cryostat 
sections to indicate P M W S . Low  levels o f  P C V 2  antigen were observed in tissues. A ll 
pigs had maternal antibodies to P C V 2  and were seen to serologically respond on the 6 
herd visit, at approxim ately 60 days o f  age (F igure 5.3) except pigs 35 and 24 who had a 
final titre o f  50.
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Figure 5.3: P C V 2  antibody titre o f  cohort o f  samples from  herd C over the
observation period o f  ten weeks
H e rd  D : Ten pigs died in this herd during the study (pigs no. 42, 47, 1, 9, 4, 5, 31,
43, 46  and 16). Pigs 42 and 47 died during the first w eek and their bodies were 
discarded. F ive pigs (pigs no. 9, 4, 31, 43, 4 6 ) were confirmed positive for P M W S . IF A  
on cryostat sections demonstrated high levels o f  P C V 2  antigen. Tw o  pigs (pigs no. 1, 5) 
demonstrated moderate/high levels o f  P C V 2  antigen and were described as pre-clinical 
and would like ly  develop fu ll-b low n disease. One p ig  (p ig  no. 16) had insufficient P C V 2  
antigen on cryostat sections to indicate P M W S . A ll  pigs in itia lly  had maternal antibodies 
to P C V 2 . On the 5th herd visit these maternal antibodies appeared to decline in titre. 
Most pigs were then seen to respond serologically w ith  a four-fo ld increase in titre by the 
8th farm visit, around 70 days o f  age (figure 5.4a, b, c, d and e). A ll  healthy pigs 
exhibited seroconversion, but many P M W S  affected animals failed to do so.
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Figure 5.4a: P C V 2  antibody titre o f  cohort o f  samples from  herd D  over the
observation period o f  ten weeks in litter 1
Figure 5.4b: P C V 2  antibody titre o f  cohort o f samples from  herd D  over the
observation period o f  ten weeks in litter 2
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Figure 5.4c: P C V 2  antibody titre o f  cohort o f  samples from  herd D  over the
observation period o f  ten weeks in  litter 3
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Figure 5.4d: P C V 2  antibody titre o f  cohort o f  samples from  herd D  over the
observation period o f  ten weeks in litter 4
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Figure 5.4e: P C V 2  antibody titre o f  cohort o f  samples from herd D  over the
5 .4 .1 .2  P P  V A n a ly s is
To determine i f  P P V  infection levels play a role in the pathogenesis o f  fie ld  cases 
o f P M W S , serum samples were tested using an E L IS A  for the presence o f  PPV  
antibodies over the same time-course as for P C V 2  Antibody titre. Results were classified 
as negative, positive and strongly positive as detailed in chapter 2 .5.6.1 .
H e rd  A : Three o f  the pigs from  the cohort tested were P P V  antibody negative. Pig
56 and 51 had declining antibody levels when they died. A ll  other pigs were strongly 
positive for P P V  antibodies, (figure 5 .5).
observation period o f  ten weeks in litter 5
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Figure 5.5: P P V  percent inhibition in herd A
H e rd  B: A ll  pigs were strongly positive for antibodies to P P V  on the first date they
were bled, i.e. 2nd herd visit. M ost pigs in the cohort retained their maternal antibodies 
until towards the end o f  the 10 weeks (figure 5 .6). A ll  pigs had been vaccinated for P P V . 
Seven o f  the pigs did lose their maternal antibodies and on the 7th visit they were P P V  
antibody negative. One o f  these animals was pig no. 42, w hich was confirmed as P M W S  
positive.
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Figure 5.6: P P V  percent inhibition o f  P P V  in herd B
H e rd  C : Four o f  the tw enty pigs tested from  this herd were P P V  antibody negative.
One o f  these pigs (pig no. 35 ) was seen to respond serologically. A ll  pigs had been 
vaccinated for P P V . Pig no. 23 was also seen to respond serologically after the 5th 
sampling date, (F igure 5 .7).
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Figure 5.7: P P V  percent inhibition o f  P P V  in herd C
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H e rd  D : Eighteen o f  the 51 pigs tested from  herd D  were antibody negative on the
first bleed and were not demonstrated to respond serologically. A ll  P P V  antibody 
positive pigs showed a decline in maternal antibodies throughout the 10 weeks (figure 5.8 
and 5 .9). Tw enty-six  o f  these antibody positive pigs lost all their maternal antibodies and 
did not serologically respond. Seven o f  the pigs retained their maternal antibodies; 
however 5 o f  these 7 died during the 10 weeks observation period.
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Figure 5.9: Percent Inhib ition o f  P P V  in herd D  pigs 26-51
5.4.2  Iso la tion  o f  haem olytic  E .c o l i ,  C a m p y lo b a c te r  a n d  S a lm o n e lla  species fro m
faecal swabs
These swabs were analysed im m ediately upon arrival into the laboratory as 
described in chapter 2  and 5.2. There appeared to be an increase in the isolation o f  
haemolytic E .c o l i  w ith  tim e in  all four herds, resulting in a 96 -  100%  isolation rate from  
faeces in this study. Suspect haem olytic E. c o l i  isolates were stored on beads at -20°C  
until all samples had been analysed. In  order to identify the most commonly isolated 
E n te ro b a c te r ia c e a e  an A P I®  20E  test was perform ed on stored isolates. E. c o l i  1 was 
the most common isolate, w ith  sporadic isolation o f  E. c o l i  2  from  all four herds. On one 
occasion in herd “B ” (p ig 42 ) C it ro b a c te r  b ra a k i i  was identified. C a m p y lo b a c te r  species 
(w ith  C a m p y lo b a c te r  c o l i  the most com m only isolated) were almost com m only isolated
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throughout the 10 weeks. The isolation o f  S a lm o n e lla  was sporadic and none were 
detected in  herds “C ” and “D ” (Table 5.1, 5.2, 5.3 and 5.4).
H aem olytic E. c o l i  was isolated from  pig 56 herd A  from  the first herd visit, 
C a m p y lo b a c te r  spp. w ere not isolated until the third visit and S a lm o n e lla  spp. were 
isolated on the fourth herd visit. In  herd B, p ig  36, haem olytic E. c o l i  and S a lm o n e lla  
spp. were isolated from  the first herd visit and C a m p y lo b a c te r  spp. was isolated from  the 
second visit. In  the case o f  p ig  42, haemolytic E . c o l i  was isolated from  the first visit, 
C a m p y lo b a c te r  spp. were isolated from  the second v isit and there was no S a lm o n e lla  
species isolated from  this pig. In  herd D , haem olytic E . c o l i  were isolated from  the first 
v isit in  pigs 4, 9 and 46 and C a m p y lo b a c te r  spp. was isolated from  the first visit and in  
pigs 31 and 43 C a m p y lo b a c te r  spp. was isolated from  the second visit. N o  S a lm o n e lla  
was isolated from  herd D .
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Sampling No. No. of haemolytic E. 
co li isolated/No. 
examined
No. Cam pylobacter 
spp. Isolated/No. 
examined
No. Salm onella spp. 
Isolated/No. examined
1 18/55 40/55
30%2,60%\l0%4
0/55
2 17/52 49/521, 60%',40%' 1/52
3 30/52 46/52',100%' 0/52
4 46/50 50/50', 94%',6%J 1/50
5 41/52 51/521, 80%",20%J 0/52
6 46/52 52/52', 100%' 1/52
1 49/51 50/51', 100%“* 4/52
1 No. of positive Campylobacter isolates 
; % of Campylobacter coli isolates from 10 tested
3 % of Campylobacter jejuni isolates from 10 tested
4 % of Campylobacter lari isolates from 10 tested
Table 5.1: Isolation o f  haem olytic E. c o l i,  C a m p y lo b a c te r  spp. and S a lm o n e lla  spp.
from  faecal swabs in  herd A  over the observation period
Sampling No. No. of haemolytic E . 
c o li isolated/No. 
examined
No. Cam pylobacter 
spp. isolated/No. 
examined
No. Salm onella spp. 
Isolated/No. examined
1 38/51 42/51* 5/51
2 47/49 43/49’ 1/49
3 47/51 51/511 0/51
4 40/50 50/501 1/50
5 48/48 48/48' 1/48
6 46/46 46/461 0/46
7 45/47 47/471 0/47
1 No. of positive Campylobacter isolates
2 % of Campylobacter coli isolates from 10 tested
3 % of Campylobacter jejuni isolates from 10 tested
4 % of Campylobacter lari isolates from 10 tested
Table  5.2: Isolation o f  haem olytic E . c o l i,  C a m p y lo b a c te r  spp. and S a lm o n e lla  spp.
from  faecal swabs in  herd B  over the observation period
137
Sampling No. No haemolytic E . co li 
isolated/No. examined
No. Cam pylobacter 
spp. Isolated/No. 
examined
No. Salm onella spp. 
Isolated/No. examined
1 42/55 42/51' 0/55
2 51/55 39/55' 0/55
3 53/55 54/55* 0/55
4 52/55 52/55’ 0/55
5 51/54 46/541 0/54
6 54/54 30/54' 0/54
7 38/54 51/54' 0/54
1 No. of positive Campylobacter isolates
2 % of Campylobacter coli isolates from 10 tested
3 % of Campylobacter jejuni isolates from 10 tested 
4% of Campylobacter lari isolates from 10 tested
Tab le  5.3: Isolation o f  haem olytic E . c o l i,  C a m p y lo b a c te r  spp. and S a lm o n e lla  spp,
from  faecal swabs in  herd C  over the observation period
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Sampling No. No. of haemolytic E. 
c o li isolated/No. 
examined
No. Cam pylobacter 
spp. Isolated/No. 
examined
No. Salm onella spp. 
Isolated/No. examined
1 31/51 40/51', 100%' 0/51
2 30/49 48/49', 50%',40%3 
10%4
0/49
3 27/49 49/49',80%' 
20%3
0/49
4 36/49 45/49‘, 90%',10%J 0/49
5 44/48 47/481, 100%' 0/48
6 34/46 39/46', 80%' 
20%3
0/46
1 28/42 42/42', 100%' 0/42
1 No. of positive Campylobacter isolates
2 % of Campylobacter coli isolates from 10 tested
3 % of Campylobacter jejuni isolates from 10 tested
4 % of Campylobacter lari isolates from 10 tested
Table 5.4: Isolation o f  haemolytic E. c o l i ,  C a m p y lo b a c te r  spp. and S a lm o n e lla  spp.
from  faecal swabs in  herd D  over the observation period
5.4.3  V iru s  Iso la tion
V irus isolation was perform ed on tonsil and faecal swabs, stored in  V T M , on 
p rim ary  p ig  kidney cells. Samples from  herds B , C  and D  were examined.
H e rd  B : In  herd B  the m ain  virus isolated was enterovirus 1 w ith  sporadic isolates
o f  enterovirus 2 and reovirus. Pigs 36 and 42 were the only tw o animals confirmed as 
P M W S  positive in  this herd; porcine enterovirus 1 and 2 (now  know n as porcine  
teschovirus 1 and 2 ) w ere isolated on sampling dates 6 and 7 from  pig 42 w hile  no virus 
was detected from  p ig  36 (Tab le 5.5).
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Pig SAMPLING SAMPLING SAMPLING SAMPLING SAMPLING SAMPLING SAMPLING
ID 1 2 3 4 5 6 7
B.102 Tonsil NVI NVI NT NVI NVI Entero 1
Faeces NT NVI NVI NVI Entero 1 Entero 1/Reo
B.107 Tonsil NVI NVI NVI Entero 1 NVI NVI
Faeces bact NVI NVI NVI NT Entero 1
B.109 Tonsil NVI NVI NVI NVI Entero 1 Entero 1
Faeces NVI NVI NVI NVI Entero 1 NVI
B.112 Tonsil NVI NVI NVI NVI NVI Entero 1
Faeces NVI NVI NVI NVI Entero 1 Entero 1
B.117 Tonsil NVI NVI NVI NVI NVI Entero 1
Faeces NVI NVI NVI NVI Entero 1 Entero 1
B.122 Tonsil NVI NVI NVI NVI No
Samples
NVI Entero 1
Faeces NVI NVI NVI NVI NT Entero 1
B.123 Tonsil NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI NT Entero 1
B.124 Tonsil NVI NVI NVI NVI NVI Entero 1
Faeces NVI NVI NVI NVI Entero 1 Entero 1
B.125 Tonsil NT NVI NVI NT NT NT
Faeces NVI NVI NVI NT NT NT
B.129 Tonsil NVI NVI NVI Entero 1 NVI NVI
Faeces NVI NVI NVI Entero 1 Entero 1 Bact
B.131 Tonsil NVI NVI NVI NVI NVI Entero 1
Faeces NVI NVI NVI fungus Entero 1 Entero 2
B.135 Tonsil NVI NVI NVI NT NVI NVI
Faeces NVI NVI NVI NVI NVI Entero 2/Reo
B.136 Tonsil NVI NVI NT NVI PMWS
Faeces NVI NVI NVI NVI
B.137 Tonsil NVI NVI NVI NVI Entero 1 NVI
Faeces NVI NT NVI NVI Entero 1 NVI
B.140 Tonsil NVI NVI NVI NVI NT NT
Faeces NVI NVI NT NVI NT NT
B.142 Tonsil NVI NVI NVI NVI Entero 1 Entero 1 & 2
Faeces NVI NVI NVI NVI Entero 1 Entero 1
B.144 Tonsil NVI NVI NVI NVI NT Entero 1
Faeces NVI NVI NVI Bact NT Reo
B.148 Tonsil NVI NVI NVI NVI Entero 1 NVI
Faeces NVI NVI NVI NVI Entero 1 Entero 1,2 & 
Reo
B.149 Tonsil NVI NVI NVI NT NT NT
Faeces NVI NVI NVI Entero 2 NT NT
B.150 Tonsil NVI NVI NVI NVI NVI Reo
Faeces NVI NVI NVI NVI Entero 1 Entero 1
B.154 Tonsil NVI NVI NVI Entero 1 NVI Entero 1
Faeces NVI NVI NVI Entero 1 Entero 1 Reo
NVI: No vims Isolated 
NT: Not tested
Table  5.5: V irus Isolation from  tonsil and faecal swabs in  V T M  in  herd B
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H e rd  C : In  herd C, porcine enterovirus 1 was the m ain virus isolated and this was
on the 4th, 5th’ 6th and 7th sampling dates. Adenovirus was also isolated from  pigs 45 and 
49 on the 5th and 6th sampling dates. Porcine enterovirus 2 was not isolated from  this 
herd (Tab le  5.6).
Pig
ID
Sampling
1
Sampling
2
Sampling
3
Sampling
4
Sampling
5
Sampling
6
Sampling
7
C.l Tonsil NVI NVI NVI Entero 1 NVI Bact Entero 1
Faeces NVI NVI NVI NVI NVI Entero 1 NVI
C.5 Tonsil NVI NVI NVI NVI Died
Faeces NVI NVI NVI NVI
C.6 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI NVI Entero 1 Entero 1
C.10 Tonsil NVI NVI NVI NVI NVI NVI Entero 1
Faeces NVI NVI NVI NVI NVI Entero 1 Entero 1
C.16 Tonsil NVI NVI bact NVI NVI NVI NVI
Faeces NVI NVI NVI NVI NVI bact Entero 1
C.17 Tonsil NVI NVI NVI NVI NVI NVI Entero 1
Faeces NVI NVI NVI NVI Entero 1 Entero 1 Entero 1
C.23 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI NVI NVI NVI
C.24 Tonsil NVI NVI NVI NVI NVI NVI NVT
Faeces NVI NVI NVI NVI NVI NVI NVI
C.25 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI NVI Entero 1 Entero 1
C.29 Tonsil NVI NVI NVI NVI Entero 1 NVI NVI
Faeces NVI NVI NVI NVI NVI Entero 1 NVI
C.30 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI NVI Entero 1 NVI
C.35 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI NVI NVI Entero 1/PCV2
C.39 Tonsil NVI NVI NVI NT NVI NVI NVI
Faeces NVI NVI NVI NVI NVI Entero 1 NVI
C.42 Tonsil NVI NVI NVI NVI Entero 1 NVI NVI
Faeces NVI NVI NVI NVI Entero 1 Entero 1 Entero 1
C.45 Tonsil NVI NVI NVI NVI NVI Adeno/PCV2 Entero 1
Faeces NVI NVI NVI NVI Entero 1 ND Entero 1
C.49 Tonsil NVI NVI NVI Entero 1 NVI NVI NVI
Faeces NVI NVI NVI NVI Entero 1/Adeno NVI NVI
C.52 Tonsil NVI NVI NVI NVI Entero 1 Entero 1 ?NVI
Faeces NVI NVI ND Entero 1 NVI NVI Entero 1
C.55 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI NVI NVI Entero 1
C.56 Tonsil NVI NVI NVI Entero 1 Entero 1 NVI Entero 1
Faeces NVI NVI NVI NVI Entero 1 Entero 1 NVI
NVI: No virus Isolated 
NT: Not tested
Table 5.6: V irus Isolation from  tonsil and faecal swabs in  V T M  in herd C
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H e rd  D :  Adenovirus was isolated from  this herd as early  as the 1st sampling date.
Porcine enterovirus 1 and 2  and reovirus were also isolated. Reovirus was on ly  isolated 
on the fina l herd visit. Enteroviruses 1 and 2 were isolated on visits 4, 5, 6 and 7 (Table
5 .7). In  p ig  9, adenovirus was isolated on sampling date 3 and enterovirus 2 was isolated 
on sampling date 4. In  p ig  4, enterovirus 1 was isolated on sampling date 6. N o  virus 
was isolated from  p ig  31. In  pig 43, adenovirus was isolated on sampling date 3 and 
enterovirus 1 was isolated on sampling dates 5 and 6. In  p ig  46 , enterovirus 2 was 
isolated on sampling date 5 and enterovirus 1 on sampling date 6.
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Primary pig kidney virus isolation
Piglet ID Sample ID Sampling
1
Sampling
2
Sampling
3
Sampling
4
Sampling
5
Sampling
6
Sampling
7
D.l Tonsil NVI NVI NVI NVI NVI In poor condition euthanased after 
sampling 5 
Pre-clinical
Faeces NVI ADENO Adeno-cpe entero cpe 2 NVI
D.2 Tonsil NVI NVI NVI NVI NVI entero cpe 1 REO
Faeces NVI NVI ADENO entero cpe 1 NVI NVI entero cpe 1
D.3 Tonsil NVI NVI NVI entero cpe 2 NVI NVI NVI
Faeces NVI NVI NVI NVI entero cpe 1 NVI entero cpe 1
D.4 Tonsil NVI NVI NVI NVI NVI NVI
PMWSFaeces NVI NVI NVI NVI NVI entero cpe 1
D.5 Tonsil NVI NVI NVI NVI NVI NVI
PRE-CUNFaeces NVI NVI ADENO NVI entero cpe 1 NVI
D.6 Tonsil NVI NVI NVI NVI NVI NVI entero cpe 1
Faeces NVI ADENO ADENO NVI entero cpe 1 NVI entero cpe 1
D.7 Tonsil NVI NVI NVI NVI NVI entero cpe 1 NVI
Faeces NVI NVI Adeno-cpe NVI NVI entero cpe 1 REO
D.8 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI Re-inoc entero cpe 1 entero cpe 1
D.9 Tonsil NVI NVI NVI NVI NVI
PMWSFaeces NVI NVI Adeno-cpe entero cpe 2 NVI
D.10 Tonsil NVI NVI NVI NVI Very small pig in v. poor condition died; discarded by 
farmer.Faeces NVI NVI NVI NVI
D.l t Tonsil NVI NVI NVI entero cpe 2 NVI NVI NVI
Faeces NVI NVI NVI Adeno-cpe entero epe 2 entero cpe 1 NVI
D.12 Tonsil NVI NVI NVI NVI NVI entero cpe 1 NVI
Faeces NVI NVI NVI NVI NVI entero cpe 1 entero epe 1
NVI: No viras Isolated 
NT: Not tested
Table  5.7: V irus Isolation from  tonsil and faecal swabs in  V T M  in herd D
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Piglet ID Sample ID Sampling
1
Sampling
2
Sampling
3
Sampling
4
Sampling
5
Sampling
6
Sampling 
7 Wat-85 
5/7/04
D.I3 Tonsil NVI NVI NVI NVI entero cpe 2 entero cpe 1 REO
Faeces NVI NVI NVI NVI NVI NVI REO
D.14 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI ADENO ? mod entero 
type3
?? only weak cpe 
2
entero cpe 1 entero cpe 1
D.15 Tonsil NVI NVI NVI NVI NVI entero cpe 1 REO
Faeces ADENO NVI ADENO entero cpe 2 NVI NVI NVI
D.16 Tonsil NVI NVI NVI NVI NVI NVI REO
Faeces NVI NVI NVI entero cpe 2 NVI entero cpe 1 entero cpe 1
D.17 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI NVI NVI NVI
D.18 Tonsil NVI NVI NVI Adeno-cpe NVI NVI NVI
Faeces NVI NVI NVI entero cpe 3 NVI entero cpe 1 REO
D.19 Tonsil NVI NVI NVI NVI NVI entero cpe 1 NVI
Faeces NVI NVI NVI entero cpe 2 Re-inoc entero cpe 1 entero cpe 1
D.20 Tonsil NVI NVI NVI Adeno-cpe NVI NVI NVI
Faeces NVI NVI NVI NVI NVI NVI entero cpe 1
D.21 Tonsil NVI NVI NVI NVI NVI NVI REO
Faeces NVI NVI NVI NVI NVI entero cpe 1 REO
D.22 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI NVI entero cpe 1 NVI
D.23 Tonsil NVI NVI NVI ADENO NVI entero cpe 1 REO
Faeces NVI NVI NVI NVI entero cpe 1 NVI NVI
D.24 Tonsil NVI NVI NVI NVI NVI NVI REO
Faeces NVI NVI NVI NVI NVI entero cpe 1 entero cpe 1
NVi: No virus Isolated 
NT: Not tested
Table 5.7: V irus Isolation from  tonsil and faecal swabs in V T M  in  herd D  (continued)
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Prim ary pig kidney virus isolation
Piglet ID Sample ID Sampling 
1 Wat-50 
5/5/04
Sampling 
2 Wat-52 
17/5/04
Sampling 
3 Wat-56 
27/5/04
Sampling 
4 Wat-69 
7/6/04
Sampling 
5 Wat-72 
16/6/04
Sampling 
6 Wat-79 
24/6/04
Sampling 
7 Wat-85 
5/7/04
D.25 Tonsil NVI NVI NVI ADENO NVI entero cpe 1 NVI
Faeces NVI NVI NVI NVI NVI entero cpe 1 entero cpe 1 & 
REO
D.26 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI Re-inoc NVI entero ene 1 entero cpe 1
D.27 Tonsil NVI NVI NVI NVI NVI entero cpe 1 Re-inoc
Faeces NVI NVI NVI Re-inoc NVI entero cpe 1 entero cpe 1
D.28 Tonsil NVI NVI NVI NVI NVI NVI REO
Faeces NVI NVI NVI Re-inoc entero cpe 1 entero cpe 1 NVI
D.29 Tonsil NVI NVI NVI NVI entero cpe 2 NVI NVI
Faeces NVI NVI NVI entero cpe 1 NVI entero cpe 1 NVI
D.30 Tonsil NVI NVI NVI NVI NVI entero cpe 1 NVI
Faeces NVI NVI NVI entero cpe 1 NVI NVI entero cpe 1
D.31 Tonsil NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI NVI NVI PMWS
D.32 Tonsil NVI NVI NVI NVI NVI entero cpe 1 REO
Faeces NVI NVI NVI NVI entero cpe 1 NVI REO
D.33 Tonsil NVI NVI NVI ADENO NVI NVI NVI
Faeces NVI NVI NVI NVI entero cpe 1 entero cpe 1 entero cpe 1
D.34 Tonsil NVI NVI NVI NVI NVI entero cpe 1 NVI
Faeces Re-inoc NVI NVI entero cpe 1 entero cpe 1 entero cpe 1 REO
D.35 Tonsil NVI NVI NVI NVI NVI entero cpe 1 NVI
Faeces NVI NVI NVI NVI NVI entero cpe 1 NVI
NVI: No virus Isolated 
NT: Not tested
Table 5.7: Virus Isolation from tonsil and faecal sw abs in V T M  in herd D  (continued)
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Priman' pig kidney vims iso la lion
Piglet ID Sample ID Sampling 
1 Wat-50
5/5/04
Sampling 
2 Wat-52 
17/5/04
Sampling 
3 Wat-56 
27/5/04
Sampling 
4 Wat-69 
7/6/04
Sampling 
5 Wat-72 
16/6/04
Sampling 
6 Wat-79 
24/6/04
Sampling 
7 Wat-85 
5/7/04
D.36 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI Re-inoc entero cpe 1 entero cpe 1 entero cpe 1
D.37 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI ADENO ADENO NVI NVI NVI entero cpe 1
D.38 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI NVI NVI entero cpe 1 entero cpe 1 entero cpe 1
D.39 Tonsil NVI NVI NVI NVI entero cpe 1 entero cpe 1 NVI
Faeces NVI NVI NVI NVI NVI
D.40 Tonsil NVI NVI NVI ADENO NVI NVI REO
Faeces NVI NVI NVI NVI entero cpe 1 REO
D.41 Tonsil NVI NVI NVI Re-inoc entero cpe 2 NVI NVI
Faeces NVI NVI NVI entero cpe 3 NVI REO
D.42 Tonsil NVI Died shortly after first bleed; not necropsied
Faeces NVI
D.43 Tonsil NVI NVI NVI NVI entero cpe 1 NVI NVI
Faeces NVI NVI ADENO Re-inoc NVI entero cpe 1 NVI
D.44 Tonsil NVI NVI NVI NVI NVI NVI NVI
Faeces NVI NVI ADENO NVI entero cpe 1 entero cpe 1 entero cpe 1
D.45 Tonsil NVI NVI NVI NVI NVI NVI REO
Faeces NVI NVI ADENO NVI NVI NVI REO
D.46 Tonsil NVI NVI NVI NVI entero cpe 2 NVI ND
Faeces NVI NVI NVI NVI NVI entero cpe 1 ND
NVI: No virus Isolated 
NT: Not tested
Table 5.7: V irus Isolation from tonsil and faecal sw abs in V T M  in herd D  (continued)
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Primary pig kidney virus isolation
Piglet ID Sample ID Sampling 
1 Wat-50 
5/5/04
Sampling 
2 Wat-52 
17/5/04
Sampling 
3 Wat-56 
27/5/04
Sampling 
4 Wat-69 
7/6/04
Sampling 
5 Wat-72 
16/6/04
Sampling 
6 Wat-79 
24/6/04
Sampling 
7 Wat-85 
5/7/04
D.47 Tonsil NVI Died shortly after first bleed; not necropsied
Faeces NVI
D.48 Tonsil NVI NVI NVI NVI NVI NVI ?? Only weak 
cpe 3
Faeces NVI NVI NVI entero cpe 2 NVI NVI NVI
D.49 Tonsil NVI NVI NVI NVI NVI REO
Faeces Re-inoc NVI NVI NVI entero cpe 1 entero cpe 1 NVI
D.50 Tonsil NVI NVI NVI ADENO NVI NVI REO
Faeces NVI NVI NVI entero cpe 1 entero cpe 1 NVI NVI
D.51 Tonsil NVI NVI NVI NVI Adeno-cpe entero cpe 1 NVI
Faeces NVI NVI NVI entero cpe 3 entero cpe 1 entero cpe 1 entero cpe 1
NVI: No virus Isolated 
NT: Not tested
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A ll pigs tested from the four herds were positive for maternal antibodies to PCV2. 
M ost pigs were seen to respond serologically b y  the final herd visit. In herds B  and D  
those pigs w h ich  were confirmed as PM W S positive did not appear to mount an active 
immune response as no increase in titre w as observed. In herd D, pigs 1 and 5, which  
w ere described as pre-clinical, did appear to respond serologically. A ctive  
seroconversion to PC V 2 generally occurs at 8 to tw elve w eeks o f  age (Segales and 
Dom ingo, 2002). In herds B  and C, pigs were seen to respond serologically at sixty to 
seventy days o f  age (approxim ately 8 to 10 w eeks) and in herds A  and D  from 40 to 60 
days o f  age (approxim ately 6 to 8 w eeks). It has been reported that PC V 2 infection or 
lo w  serological titres to PC V 2 in sow s at farrowing had a significant effect on the overall 
mortality o f  their offspring due to PM W S (A llan et al., 2005). Conversely, m ore recent 
studies have shown that high levels o f  antibody to PC V 2 in sow s and gilts does not result 
in protection from PM W S in the piglets derived from these animals (H assing et al., 2004; 
A llan  et al., 2005). H ow ever, the protective effect o f  maternal passive im m unity on  
PM W S developm ent is supported b y  the fact that disease occurs once titres have declined  
(A llan et al., 2005). This is supported b y  the findings in herds B and D. Therefore 
measures that increase maternal immunity and decrease so w  viraemia at farrowing m ay  
diminish P M W S impact on pig mortality.
H ow ever, it has been reported elsewhere that seroprofiles from positive and 
negative herds are not very  different (Rodriguez-Arrioja et al., 2000; Sibila, 2001; 
Larochelle et al., 2003) and the prevalence and distribution o f  PC V 2 in positive and
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negative herds are not very  different (Ladekjaer-M ikkelsen, 2003). For this reason it is 
necessary to maintain the health balance in a herd, measures em ployed to maintain the 
health balance, such as M adec’s 20 principles, w ill also assist in avoiding spread betw een  
animals (M arco, 2005).
P PV  is endem ic in sw ine populations and m any weaned pigs m ay be  infected with  
PPV . It has been extensively reported through experimental m odels that concurrent 
infection w ith  P P V  and PC V 2 has increased the severity o f  lesions, suggesting this and 
other agents m ay p lay  an important role in m odifying the clinical and pathological 
expression o f  PC V 2 infection (K ennedy et al., 2000). In order to determine i f  PPV  
enhanced PC V 2 infection and so played a role in field cases o f  PM W S in Ireland a 
commercial E L IS A  (Svanovir™ ) w as used on the four herds in this study to determine 
P P V  antibody titre. A  decline in maternal antibodies w as observed in p ig  56 in herd A ; in 
herd B, p ig  42 had lost all maternal antibodies and pig 36 w as still antibody positive; in 
herd D  pigs 9 and 4 were P P V  antibody negative throughout the ten w eeks and pigs 31, 
43 and 46 were P P V  antibody positive throughout the ten weeks. From  the results in the 
present study it can be concluded that although in som e cases P PV  m ay lead to an 
increase in the severity o f  the disease it is not one o f  the crucial co-factors.
H aem olytic E. coli and Campylobacter spp. were isolated from faeces from all 
four herds and Salmonella spp. w as isolated sporadically from faeces from herds A  and
B. There appeared to be an increase in the isolation o f  E. coli w ith  time in all four herds 
and Campylobacters appear to be ubiquitious in the pig population, w ith  Campylobacter
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coli the m ost com m only isolated species in this study. These organisms m ay cause 
diarrhoea and oedem a in pigs; how ever there appeared to be  no difference in the isolation 
rate o f  these organisms from diseased and non-diseased pigs in Irish herds.
The m ost com m only isolated viruses in this study were found to be  porcine 
enterovirus 1 and 2 and reovirus in ROI herds and porcine enterovirus 1 and 2, reovirus 
and adenovirus in N I herds. Porcine enteroviruses are enteric viruses, host specific to the 
pig, that are included in the group called "SM ED I viruses" (Stillbirth, M ummification, 
Em bryonic Death and Infertility). The enteroviruses are subdivided into serotypes o f  
w hich  at least 11 are known. Four o f  these, serotypes 1, 3, 6 and 8, have been implicated  
in reproductive problem s in pigs. Serotype 1 is the Teschen/Talfan virus w hich  can also 
cause paralysis in pigs. Usually, each pig herd has an array o f  different serotypes which  
circulate sub-clinically in w eaned and young growing pigs w hich  are protected b y  
circulatory antibodies derived from their dam's colostrum. B y  the time they reach  
breeding age they are solidly immune
(http://www.thepigsite.com/pighealth/article/139/enteroviruses-smedi). The com m on  
m ode o f  enterovirus transmission is b y  oral exposure to contaminated faeces. 
Enteroviruses m ay contaminate sem en via aerosols during collection o f  sem en and can 
cause foetal and neonatal death. (Guerin and Pozzi, 2005). Reoviruses have been  
implicated in relation to infertility or reproductive disorders in pigs (Guerin and Pozzi, 
2005). These viruses can be readily detected in faeces, and m ay also be recovered from  
pharyngeal or nasal secretions, urine, cerebrospinal fluid and blood. Adenoviruses are a 
group o f  viruses that infect the membranes (tissue linings) o f  the respiratory tract, the
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eyes, the intestines, and the urinary tract; adenoviruses are a cause o f  acute respiratory 
infections and are a frequent cause o f  diarrhoea in pigs (Guerin and Pozzi, 2005).
In herd B, o f  the pigs affected w ith  PM W S, porcine enterovirus 1 and 2 were  
isolated from p ig  42, w h ile  no virus w as isolated from pig 36. In herd D enterovirus 1 
w as isolated from pig 4, adenovirus and enterovirus 2 w as isolated from pig 9, no virus 
w as detected in pig 31, adenovirus and porcine enterovirus 1 w as isolated from pig 43 
and porcine enterovirus 1 and 2 were isolated from pig 46. There w as no com m on virus 
isolated from every p ig  which  died as a result o f  PM W S. It is therefore unlikely that 
these viruses, porcine enterovirus 1 and 2, reovirus and adenovirus when  co-infected with  
P C V 2 act as a trigger for PM W S.
A lthough there w as no com m on C PE virus isolated from all diseased animals in 
the farms under study, all animals were probably co-infected w ith  other viruses, animals 
36 from herd B  and 31 from herd D  w ere P P V  antibody positive w hen  tested b y  an 
E L IS A . N o  unidentified C PE w as found on any sample. A ll animals under study were  
infected w ith  haem olytic E. coli and Campylobacter spp., however, only Salmonella spp. 
w as isolated from p ig  56 in herd A  and p ig  36 in herd B. It can be concluded therefore 
from these results that the PM W S animals under study had no distinguishing co-infection  
over otherw ise healthy animals in the four herds tested in Ireland. The only major 
difference in husbandry m anagem ent betw een  the PM W S and non-PM W S herds and the 
P M W S free herd w as the fact that it w as smaller in size. It has been reported that factors 
such as environmental conditions, the genetics o f  the pigs, the introduction o f
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bioflavonoids, vitamin E , selenium and antioxidants in the diet and meal rather than pellet 
in food m ay assist in controling the disease and its effects. H ow ever in some units there 
have been conflicting results (M arco, 2005).
The practice o f  intensive pig farming where so w  stalls are used for lower  
production costs has led to significant animal welfare issues along w ith  the possible  
introduction o f  n ew  diseases and syndromes. Indoor pig system s allow  the pigs condition  
to be monitored ensuring minimum fatalities and increased productivity. Buildings are 
ventilated and their temperature regulated. M ost domestic pig varieties are susceptible to 
heat stress, and all pigs lack sweat glands and cannot cool them selves. Pigs have a 
limited tolerance to high temperatures and heat stress can lead to death. Maintaining a 
more specific temperature within the pig-tolerance range also m aximizes growth and 
growth to feed ratio. Intensive piggeries control temperature through ventilation or drip 
water system s (dropping water to cool the system ). The overcrowding o f  pigs in barren 
environments can exacerbate problems that m ay exist in the pig population and recurrent 
viral diseases have em erged and can be more readily spread.
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This study involved the determination o f  the presence and extent o f  PC V 2  
infection and PM W S, a new ly  emerged disease syndrome in weaned pigs, in both parts o f  
Ireland. To date no such work has been has been performed on pigs in R O I on this 
econom ically important disease which  has affected countries in Europe, America, A sia  
(Chae, 2004) and has recently been reported from N e w  Zealand (Laval, 2004).
The seroprevalence o f  PC V 2 infection in Irish pig herds w as determined on a 
cohort o f  random ly chosen serum samples from the pig herd population. PC V 2 w as  
found to be w idespread in Irish pig herds whether or not PM W S occurs in them, with  
8 5 %  o f  pigs testing positive in ROI and 100%  in NI. Four o f  the 50 herds tested in ROI 
w ere antibody negative to PCV2; these 4 herds were all small hobby herds. A  further 
four h obby  herds w ere antibody positive, indicating that PC V 2 m ay exist and spread in 
both large com m ercial herds and small hobby herds. H owever, it m ay be that PCV2  
requires the circumstances found in comm ercial herds to effectively contribute to 
causation o f  PM W S, such as early weaning and small pens. This w ould  suggest that 
although the risks o f  infection are low er in smaller herds it is still extrem ely important to 
adhere to strict husbandry practices, an improvement in hygiene and a reduction o f  stress.
A  very  large variation w as observed in PC V 2 antibody titres within herds; this 
w as seen to vary from the low est (< l/2 5 0 ) to the highest titre (1/156,250) detectable w ith  
this test. A  large proportion o f  Irish herds w ere  sero-positive and a high within-herd  
seroprevalence w a s found in positive herds. It has been reported elsewhere that
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seroprofiles from PM W S-positive and negative herds are not very  different (Marco, 
2005).
Specim ens from herds clinically suspected o f  PM W S were submitted to the 
laboratory for investigation over a one-year period. O f  the 30 herds examined in ROI, 24  
w ere confirmed to have PM W S and in N I, o f  the 31 submitted, 14 w ere confirmed as 
PM W S positive. This show ed  a m uch higher incidence o f  PM W S in the herds examined  
in R O I than in N I at this time, 8 0 %  and 4 5 .2 %  respectively. Work on PC V 2 infection  
and PM W S has been  ongoing in N I since the em ergence o f  the disease and therefore 
beneficial changes m ay have already occurred in husbandry and management practices 
there w h ich  were not yet established in ROI. It m ay also be a reflection o f  the selectivity  
o f  subm issions o f  suspect cases in the present study. There are a total o f  1149 active Irish 
pig herds in ROI, and it m ay be  the case that sam ples from suspect PM W S herds were not 
submitted as frequently in the South o f  Ireland. A lthough laboratory confirmation o f  the 
disease is necessary it is possible that m any specialist p ig  veterinarians m ay have  
clinically recognized PM W S or other diseases in herds and therefore m ade diagnoses 
w ithout submitting suspect samples to the laboratory, thereby having the effect o f  
reducing the num ber o f  submissions.
The principal clinical and necropsy findings observed in positive herds in 
Northern Ireland and the Republic o f  Ireland included wasting, respiratory distress, 
lym ph node enlargement, diarrhoea and pneumonia. W asting w as the m ost comm on  
finding in both N I and ROI. The principal histopathology findings included lym phocytic
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depletion, bronchopneumonia, renal oedema and cytoplasm ic inclusion bodies typical o f  
PC V 2 infection. Clinical signs observed, post-mortem changes and histopathology  
findings accorded w ith  those described in the literature for PM W S (Segales and 
Dom ingo, 2002).
Sequencing o f  PC V 2 from Irish herds w as performed. Isolates from tissues from  
field cases o f  PM W S and from non-diseased animals w ere amplified b y  PC R  and 
sequenced in order to determine i f  differences existed betw een  them, or i f  Irish isolates 
differed from isolates in other countries. The com plete genom e o f  PCV2 isolates were  
aligned using ClustalW  version 1.83 multiple sequence alignment programme 
http://www.ebi.ac.uk/clustalw/. A ligned data demonstrated that all the isolates from  
Ireland show ed  a m inim um  hom ology o f  9 7 %  w ith  each other, and when compared to 
those from other countries, show ed a minimum hom ology o f  94 % .
The tw o  major open reading frames o f  PC V 2, ORF1 and O RF2 were examined. 
ORF1 codes for the Rep protein (Cheung, 2004a), while O R F2 codes for the capsid  
protein (A llan and Ellis, 2000a). A n  amino acid alignment w as also preformed on these  
O R F ’s using the ClustalW  programme. Within ORF1 the minimum hom ology observed  
betw een  isolates from both parts o f  Ireland w as found to be 9 8 %  and in O R F2 the 
minimum hom ology w a s 9 4 % . W hen comparing PC V 2 isolates from diseased animals 
w ith  those from non-diseased animals, it w as observed that som e amino acid changes 
existed w ithin these O R Fs. A s the O RF2-encoded protein is the major structural antigen  
o f  the virus, changes to its primary sequence m ay result in an altered immune response to
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PC V 2, either due to an alteration o f  T cell immunoreactive epitopes or to the binding  
sites for neutralising antibodies. N o  nucleotide changes w ere observed within the stem  
loop structure o f  the origin o f  replication o f  Irish PC V 2 isolates.
A  longitudinal study w as performed on four herds in Ireland, comprising 2 
diseased herds and one non-diseased herd from R O I and one diseased herd from NI. Pigs 
from 5 litters were included in the study. To determine i f  any other infectious agent w as  
present and so involved in potentiating PC V 2 to cause disease, these animals were tested  
for PC V 2 and P P V  antibody and for the presence o f  haemolytic E. coli, Campylobacter 
spp., Salmonella spp. and other viral pathogens. There did not appear to be any  
difference in the isolation rates o f  viruses and bacteria betw een  the diseased and non­
diseased animals and herds. Therefore it can be concluded that the PM W S animals under 
study did not appear to have a distinguishing co-infection over otherwise healthy animals 
in the four herds tested in Ireland. A  complete history w as taken from each herd in ROI 
in order to determine i f  there w ere any obvious difference in husbandry and management, 
from the information given  the only major difference betw een  the PM W S affected and 
non-affected herds w a s size. This w ould  suggest that the m ost effective control measures 
are improved m anagem ent and control o f  other pathogens and to reduce stresses that m ay  
be brought about b y  overcrowding. It m ay be worth investigating the size o f  pig herds as 
a w hole and its implication in the spread o f  disease.
PM W S has had major econom ic, public health and animal welfare impacts on the 
pig m eat industry. Econom ic looses have been reported as more than €600 m illion per
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year to the European Union (A llan et al., 2005). Factors underlying the econom ic losses 
include few er pigs at slaughter, reduced feed conversion rates, increased costs for 
management, m edication o f  sick pigs and costs o f  secondary diseases follow ing PM W S  
associated immunosupression. The potential impact o f  PM W S in terms o f  food safety  
and veterinary public health is only beginning to emerge. PM W S associated  
immunosuppression m ay result in increased carcase contamination b y  food-borne 
pathogens (eg. Salmonella typhimurium) arising from potentially increased prevalence o f  
infection on-farm and increased shedding at slaughter. A  second public health concern is 
an associated increase in the use o f  antimicrobial agents in the attempted control o f  
PM W S-associated disease, w ith  consequently increased potential for selecting for 
antimicrobial resistant bacteria and drug residues in pig meat. In the U K , where PM W S  
em erged betw een  1998 and 1999, the use o f  antimicrobials in p ig  production increased  
m arkedly from 83 tonnes/year in 1998 to 109 tonnes/year in 2001; a 3 1 %  increase despite  
a 7 %  reduction in the U K  breeding pig population. The introduction o f  PM W S is a likely  
driver behind this increased antibiotic use. The impact o f  PM W S on pig welfare is 
m anifest through prolonged increases in mortality rates and increased numbers o f  ill- 
thriven pigs requiring hospitalization (Tucker et al., 2006).
There are m any control measures that can be used w ith  PM W S. These can be 
com bined successfully. H ow ever, there is no general protocol that w ill suit in exactly all 
herds the sam e w ay. Each individual herd w ill need to take a slightly different approach 
depending on their facilities, size and health status.
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C h a p t e r  8 :  A p p e n d i x
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P r e p a r a t i o n  o f  B u f f e r  S o lu t io n s
Hanks balanced Salt Solution (H B SS) 10X: Biosciences, Dublin
4m ls H B SS diluted in 36mls o f  
sterile distilled water w ith  a few  
drops o f  foetal ca lf serum (FC S )
Phosphate Buffered Saline (PBS):
D-glucosamine:
Sigma-Aldrich, Dublin, Ireland 
Contents o f  one pouch, when  
dissolved in one liter o f  distilled or 
deionized water, w ill yield 0.01 M  
phosphate buffered saline (NaCl 
0.138 M ; KC1 - 0.0027 M ); pH 7.4, 
at 25 °C.
Sigma-Aldrich, Dublin, Ireland
300-m M : 2.588g diluted in 36mls 
sterile distilled water +  4mls o f  
H B SS filtered through a 0.22 micron 
filter.
187
P B S  w ith  T w e en  and  H o rse  Serum  (P B S -T H ) :
Neutral Buffered Form alin (N B F):
Triphosphate buffered solution (TBS):
400m ls o f  PB S containing 4m ls o f  
0 .0 5 %  T w een  80 and 40m ls o f  horse 
serum.
1 0 %  (pH  7) in 1 litre: dissolve  
sodium  phosphate salts in 500ml o f  
water, add 100 m l formalin w ith  
stirring, adjust pH  to pH  7.0 w ith  
N aO H . M ake up to 1 liter w ith  
remaining water. Filter through  
0.45um  filter and store tightly  
capped in refrigerator.
IHC Select® 20X TBS Rinse Buffer, 
Chemicon, cat. No. 20845 
dilute this 20X Rinse Buffer to IX 
with distilled or deionized water it is 
recommended that Tween 20® be 
added to the IX Rinse Buffer at a 
final concentration of 0.1 %.
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